- All
- Gateway 16
- Country profiles 54
- Data Stories 12
- How-to articles 18
- Indicators Explorer 212
- Data 22
- Assistive Technology 97
- Global eHealth survey 2015 142
- Health Behaviour in School-aged Children (HBSC) 152
- Health 2020 indicators 40
- Child and adolescent health 37
- European mortality database (MDB) 853
- European Health for All database (HFA-DB) 599
- Environment and Health Information System (ENHIS) 55
- European database on human and technical resources for health (HlthRes-DB) 125
- Seasonal influenza vaccination policies and coverage 13
- Maternal nutrition, physical activity and weight gain during pregnancy 48
- Antimicrobial resistance 23
- Global nutrition policy survey 29
- Status of child and adolescent health policies in Europe 88
- Joint Monitoring Framework (JMF) 15
- Financial protection in the European Region 09
- European Programme of Work 44
- Rehabilitation 16
- Health-enhancing physical activity 23
- Digital Health 74
- Artificial Intelligence for Health in the WHO European Region 75
- Health information system and data governance 68
- Gateway
- Indicators Explorer
- Gross domestic product (GDP), US$ per capita (France)
- Gross domestic product (GDP), US$ per capita (Germany)
- Gross domestic product (GDP), US$ per capita (United Kingdom)
- Gross domestic product (GDP), US$ per capita (Italy)
- Gross domestic product (GDP), US$ per capita (Russian Federation)
- Gross domestic product (GDP), US$ per capita (Spain)
- Gross domestic product (GDP), US$ per capita (Türkiye)
- Gross domestic product (GDP), US$ per capita (Poland)
- Gross domestic product (GDP), US$ per capita (Portugal)
- Gross domestic product (GDP), US$ per capita (Greece)
- Gross domestic product (GDP), US$ per capita (Norway)
- Gross domestic product (GDP), US$ per capita (Denmark)
- Gross domestic product (GDP), US$ per capita (Sweden)
- Gross domestic product (GDP), US$ per capita (Switzerland)
- Gross domestic product (GDP), US$ per capita (Ireland)
- Gross domestic product (GDP), US$ per capita (Netherlands)
- Gross domestic product (GDP), US$ per capita (Ukraine)
- Gross domestic product (GDP), US$ per capita (Finland)
- Gross domestic product (GDP), US$ per capita (Austria)
- Gross domestic product (GDP), US$ per capita (Belgium)
- Gross domestic product (GDP), US$ per capita (Luxembourg)
- Gross domestic product (GDP), US$ per capita (Hungary)
- Gross domestic product (GDP), US$ per capita (Iceland)
- Gross domestic product (GDP), US$ per capita (Romania)
- Gross domestic product (GDP), US$ per capita (Georgia)
- Gross domestic product (GDP), US$ per capita (Serbia)
- Gross domestic product (GDP), US$ per capita (Bulgaria)
- Gross domestic product (GDP), US$ per capita (Estonia)
- Gross domestic product (GDP), US$ per capita (Slovakia)
- Gross domestic product (GDP), US$ per capita (Croatia)
- Gross domestic product (GDP), US$ per capita (Belarus)
- Gross domestic product (GDP), US$ per capita (Lithuania)
- Gross domestic product (GDP), US$ per capita (Latvia)
- Gross domestic product (GDP), US$ per capita (Armenia)
- Gross domestic product (GDP), US$ per capita (Albania)
- Gross domestic product (GDP), US$ per capita (Monaco)
- Gross domestic product (GDP), US$ per capita (Cyprus)
- Gross domestic product (GDP), US$ per capita (Azerbaijan)
- Gross domestic product (GDP), US$ per capita (Slovenia)
- Gross domestic product (GDP), US$ per capita (Montenegro)
- Gross domestic product (GDP), US$ per capita (Andorra)
- Gross domestic product (GDP), US$ per capita (Bosnia and Herzegovina)
- Gross domestic product (GDP), US$ per capita (Czech Republic)
- Gross domestic product (GDP), US$ per capita (Kazakhstan)
- Gross domestic product (GDP), US$ per capita (Kyrgyzstan)
- Gross domestic product (GDP), US$ per capita (Malta)
- Gross domestic product (GDP), US$ per capita (North Macedonia)
- Gross domestic product (GDP), US$ per capita (Republic of Moldova)
- Gross domestic product (GDP), US$ per capita (San Marino)
- Gross domestic product (GDP), US$ per capita (Tajikistan)
- Gross domestic product (GDP), US$ per capita (Turkmenistan)
- Gross domestic product (GDP), US$ per capita (Israel)
- Gross domestic product (GDP), US$ per capita (Republic of Uzbekistan)
- UNDP Human Development Index (HDI) (France)
- UNDP Human Development Index (HDI) (Germany)
- UNDP Human Development Index (HDI) (United Kingdom)
- UNDP Human Development Index (HDI) (Italy)
- UNDP Human Development Index (HDI) (Russian Federation)
- UNDP Human Development Index (HDI) (Spain)
- UNDP Human Development Index (HDI) (Türkiye)
- UNDP Human Development Index (HDI) (Poland)
- UNDP Human Development Index (HDI) (Portugal)
- UNDP Human Development Index (HDI) (Greece)
- UNDP Human Development Index (HDI) (Norway)
- UNDP Human Development Index (HDI) (Denmark)
- UNDP Human Development Index (HDI) (Sweden)
- UNDP Human Development Index (HDI) (Switzerland)
- UNDP Human Development Index (HDI) (Ireland)
- UNDP Human Development Index (HDI) (Netherlands)
- UNDP Human Development Index (HDI) (Ukraine)
- UNDP Human Development Index (HDI) (Finland)
- UNDP Human Development Index (HDI) (Austria)
- UNDP Human Development Index (HDI) (Belgium)
- UNDP Human Development Index (HDI) (Luxembourg)
- UNDP Human Development Index (HDI) (Hungary)
- UNDP Human Development Index (HDI) (Iceland)
- UNDP Human Development Index (HDI) (Romania)
- UNDP Human Development Index (HDI) (Georgia)
- UNDP Human Development Index (HDI) (Serbia)
- UNDP Human Development Index (HDI) (Bulgaria)
- UNDP Human Development Index (HDI) (Estonia)
- UNDP Human Development Index (HDI) (Slovakia)
- UNDP Human Development Index (HDI) (Croatia)
- UNDP Human Development Index (HDI) (Belarus)
- UNDP Human Development Index (HDI) (Lithuania)
- UNDP Human Development Index (HDI) (Latvia)
- UNDP Human Development Index (HDI) (Armenia)
- UNDP Human Development Index (HDI) (Albania)
- UNDP Human Development Index (HDI) (Monaco)
- UNDP Human Development Index (HDI) (Cyprus)
- UNDP Human Development Index (HDI) (Azerbaijan)
- UNDP Human Development Index (HDI) (Slovenia)
- UNDP Human Development Index (HDI) (Montenegro)
- UNDP Human Development Index (HDI) (Andorra)
- UNDP Human Development Index (HDI) (Bosnia and Herzegovina)
- UNDP Human Development Index (HDI) (Czech Republic)
- UNDP Human Development Index (HDI) (Kazakhstan)
- UNDP Human Development Index (HDI) (Kyrgyzstan)
- UNDP Human Development Index (HDI) (Malta)
- UNDP Human Development Index (HDI) (North Macedonia)
- UNDP Human Development Index (HDI) (Republic of Moldova)
- UNDP Human Development Index (HDI) (San Marino)
- UNDP Human Development Index (HDI) (Tajikistan)
- UNDP Human Development Index (HDI) (Turkmenistan)
- UNDP Human Development Index (HDI) (Israel)
- UNDP Human Development Index (HDI) (Republic of Uzbekistan)
- GINI coefficient (income distribution) (France)
- GINI coefficient (income distribution) (Germany)
- GINI coefficient (income distribution) (United Kingdom)
- GINI coefficient (income distribution) (Italy)
- GINI coefficient (income distribution) (Russian Federation)
- GINI coefficient (income distribution) (Spain)
- GINI coefficient (income distribution) (Türkiye)
- GINI coefficient (income distribution) (Poland)
- GINI coefficient (income distribution) (Portugal)
- GINI coefficient (income distribution) (Greece)
- GINI coefficient (income distribution) (Norway)
- GINI coefficient (income distribution) (Denmark)
- GINI coefficient (income distribution) (Sweden)
- GINI coefficient (income distribution) (Switzerland)
- GINI coefficient (income distribution) (Ireland)
- GINI coefficient (income distribution) (Netherlands)
- GINI coefficient (income distribution) (Ukraine)
- GINI coefficient (income distribution) (Finland)
- GINI coefficient (income distribution) (Austria)
- GINI coefficient (income distribution) (Belgium)
- GINI coefficient (income distribution) (Luxembourg)
- GINI coefficient (income distribution) (Hungary)
- GINI coefficient (income distribution) (Iceland)
- GINI coefficient (income distribution) (Romania)
- GINI coefficient (income distribution) (Georgia)
- GINI coefficient (income distribution) (Serbia)
- GINI coefficient (income distribution) (Bulgaria)
- GINI coefficient (income distribution) (Estonia)
- GINI coefficient (income distribution) (Slovakia)
- GINI coefficient (income distribution) (Croatia)
- GINI coefficient (income distribution) (Belarus)
- GINI coefficient (income distribution) (Lithuania)
- GINI coefficient (income distribution) (Latvia)
- GINI coefficient (income distribution) (Armenia)
- GINI coefficient (income distribution) (Albania)
- GINI coefficient (income distribution) (Monaco)
- GINI coefficient (income distribution) (Cyprus)
- GINI coefficient (income distribution) (Azerbaijan)
- GINI coefficient (income distribution) (Slovenia)
- GINI coefficient (income distribution) (Montenegro)
- GINI coefficient (income distribution) (Andorra)
- GINI coefficient (income distribution) (Bosnia and Herzegovina)
- GINI coefficient (income distribution) (Czech Republic)
- GINI coefficient (income distribution) (Kazakhstan)
- GINI coefficient (income distribution) (Kyrgyzstan)
- GINI coefficient (income distribution) (Malta)
- GINI coefficient (income distribution) (North Macedonia)
- GINI coefficient (income distribution) (Republic of Moldova)
- GINI coefficient (income distribution) (San Marino)
- GINI coefficient (income distribution) (Tajikistan)
- GINI coefficient (income distribution) (Turkmenistan)
- GINI coefficient (income distribution) (Israel)
- GINI coefficient (income distribution) (Republic of Uzbekistan)
- Area (km2) (France)
- Area (km2) (Germany)
- Area (km2) (United Kingdom)
- Area (km2) (Italy)
- Area (km2) (Russian Federation)
- Area (km2) (Spain)
- Area (km2) (Türkiye)
- Area (km2) (Poland)
- Area (km2) (Portugal)
- Area (km2) (Greece)
- Area (km2) (Norway)
- Area (km2) (Denmark)
- Area (km2) (Sweden)
- Area (km2) (Switzerland)
- Area (km2) (Ireland)
- Area (km2) (Netherlands)
- Area (km2) (Ukraine)
- Area (km2) (Finland)
- Area (km2) (Austria)
- Area (km2) (Belgium)
- Area (km2) (Luxembourg)
- Area (km2) (Hungary)
- Area (km2) (Iceland)
- Area (km2) (Romania)
- Area (km2) (Georgia)
- Area (km2) (Serbia)
- Area (km2) (Bulgaria)
- Area (km2) (Estonia)
- Area (km2) (Slovakia)
- Area (km2) (Croatia)
- Area (km2) (Belarus)
- Area (km2) (Lithuania)
- Area (km2) (Latvia)
- Area (km2) (Armenia)
- Area (km2) (Albania)
- Area (km2) (Monaco)
- Area (km2) (Cyprus)
- Area (km2) (Azerbaijan)
- Area (km2) (Slovenia)
- Area (km2) (Montenegro)
- Area (km2) (Andorra)
- Area (km2) (Bosnia and Herzegovina)
- Area (km2) (Czech Republic)
- Area (km2) (Kazakhstan)
- Area (km2) (Kyrgyzstan)
- Area (km2) (Malta)
- Area (km2) (North Macedonia)
- Area (km2) (Republic of Moldova)
- Area (km2) (San Marino)
- Area (km2) (Tajikistan)
- Area (km2) (Turkmenistan)
- Area (km2) (Israel)
- Area (km2) (Republic of Uzbekistan)
- Existence of legislation on access to assistive technology
- Legislation covering people in need of assistive technology by functional domain
- Availability of public funding for assistive technology
- Existence of responsible ministry/authority on assistive technology
- Availability of government/registered services for assistive technology
- Workforce availability for assistive technology
- Availability of education/training for assistive technology
- Existence of financial mechanisms for assistive technology
- Existence of regulations/standards/guidelines/protocols on assistive technology
- Existence of initiatives/collaborations on assistive technology
- Barriers to accessing assistive products
- Barriers to accessing assistive products, without spectacles
- Funding sources for assistive products
- Funding sources for assistive products, without spectacles
- Satisfaction with assistive products for different environments and activities
- Satisfaction with assistive products without spectacles for different environments and activities
- Satisfaction with assistive products and related services
- Satisfaction with assistive products and related services, without spectacles
- Sources of assistive products
- Sources of assistive products, without spectacles
- Travel distance to obtain assistive products
- Travel distance to obtain assistive products, without spectacles
- Travel distance to obtain assistive products for urban residents
- Travel distance to obtain assistive products for rural residents
- Met need of assistive products as proportion of need by gender
- Met need of assistive products as proportion of need by gender, no spectacles
- Met need of assistive products as proportion of need, by age
- Met need of assistive products as proportion of need, by age, no spectacles
- Met need of assistive products as proportion of need by residence
- Met need of assistive products as proportion of need by residence, no spectacles
- Prevalence of need of assistive products by gender
- Prevalence of need of assistive products by gender, no spectacles
- Prevalence of need of assistive products by age group
- Prevalence of need of assistive products by age group, no spectacles
- Prevalence of need of assistive products by residence
- Prevalence of need of assistive products by residence, no spectacles
- Prevalence of use of assistive products by gender
- Prevalence of use of assistive products by gender, no spectacles
- Prevalence of use of assistive products by age group
- Prevalence of use of assistive products by age group, no spectacles
- Prevalence of use of assistive products, by residence
- Prevalence of use of assistive products other than spectacles, by residence
- Need and use of assistive product - Alarm signalers with light/sound/vibration
- Need and use of assistive products - Audio-players with DAISY capability
- Need and use of assistive products - Grab-bars / hand rails
- Need and use of assistive products - Braille displays (note takers)
- Need and use of assistive products - Braille writing equipment/braillers
- Need and use of assistive products - Canes/sticks, tripod and quadripod
- Need and use of assistive products - Chairs for shower/bath/toilet
- Need and use of assistive products - Closed captioning displays
- Need and use of assistive products - Club foot braces
- Need and use of assistive products - Communication boards/books/cards
- Need and use of assistive products - Communication software
- Need and use of assistive products - Axillary/elbow crutches
- Need and use of assistive products - Pressure relief cushions
- Need and use of assistive products - Deafblind communicators for hearing
- Need and use of assistive products - Deafblind communicators for vision
- Need and use of assistive products - Fall detectors
- Need and use of assistive products - Gesture to voice technology
- Need and use of assistive products - GPS locators
- Need and use of assistive products - Hearing aids
- Need and use of assistive products - Hearing loops/FM systems
- Need and use of assistive products - Incontinence products, absorbent
- Need and use of assistive products - Keyboard and mouse emulation software
- Need and use of assistive products - Magnifiers, digital handheld
- Need and use of assistive products - Magnifiers, optical
- Need and use of assistive products - Manual wheelchairs, basic type for active users
- Need and use of assistive products - Manual wheelchairs, push type
- Need and use of assistive products - Pressure relief mattresses
- Need and use of assistive products - Orthoses (lower limb)
- Need and use of assistive products - Orthoses (spinal)
- Need and use of assistive products - Orthoses (upper limb)
- Need and use of assistive products - Personal emergency alarm systems
- Need and use of assistive products - Pill organizers
- Need and use of assistive products - Prostheses (lower limb)
- Need and use of assistive products - Prostheses (upper limb)
- Need and use of assistive products - Ramps, portable
- Need and use of assistive products - Recorders
- Need and use of assistive products - Rollators
- Need and use of assistive products - Screen readers
- Need and use of assistive products - Simplified phones
- Need and use of assistive products - Smartphones to support cognition
- Need and use of assistive products - Smartphones to support commucation
- Need and use of assistive products - Smartphones to support hearing
- Need and use of assistive products - Smartphones to support vision
- Need and use of assistive products - Spectacles
- Need and use of assistive products - Standing frames, adjustable
- Need and use of assistive products - Therapeutic footwear
- Need and use of assistive products - Time management products
- Need and use of assistive products - Travel aids
- Need and use of assistive products - Tricycles
- Need and use of assistive products - Video communication devices
- Need and use of assistive products - Walking frames/walkers
- Need and use of assistive products - Watches, talking/touching
- Need and use of assistive products - Wheelchairs, manual with postural support
- Need and use of assistive products - Wheelchairs, electrically powered
- Need and use of assistive products - White canes
- National universal health coverage policy or strategy exists
- National universal health coverage policy or strategy refers to the use of information and communication technology (ICT) or eHealth
- National eHealth policy or strategy exists
- National eHealth policy or strategy refers to the objectives or key elements of universal health coverage
- National health information system policy or strategy exists
- National policy or strategy on multilingualism exists
- National policy to govern the use of social media in the health professions exists
- Dedicated national telehealth policy or strategy exists
- National telehealth policy or strategy includes objectives that address telehealth's contribution to universal health coverage
- National policy or strategy on the use of social media by government organizations exists
- Public funding is available for eHealth programmes
- Private or commercial funding is available for eHealth programmes
- Donor/non-public development funding is available for eHealth programmes
- Public–private partnership funding is available for eHealth programmes
- Special funding is allocated for the implementation of the national eHealth policy or strategy
- Proportion of funding contribution for eHealth programmes provided by public funding sources over the previous two years
- Proportion of funding contribution for eHealth programmes provided by private funding sources over the previous two years
- Proportion of funding contribution for eHealth programmes provided by donor/non-public development funding sources over the previous two years
- Proportion of funding contribution for eHealth programmes provided by public–private partnership funding sources over the previous two years
- The importance of capacity as a barrier to mHealth supporting universal health coverage
- The importance of infrastructure as a barrier to mHealth supporting universal health coverage
- The importance of funding as a barrier to mHealth supporting universal health coverage
- The importance of effectiveness as a barrier to mHealth supporting universal health coverage
- The importance of cost–effectiveness as a barrier to mHealth supporting universal health coverage
- The importance of demand as a barrier to mHealth supporting universal health coverage
- The importance of legal issues as a barrier to mHealth supporting universal health coverage
- The importance of policy as a barrier to mHealth supporting universal health coverage
- The importance of priorities as a barrier to mHealth supporting universal health coverage
- Tertiary institutions provide training to students of health sciences on the use of ICT for health (eHealth)
- Proportion of tertiary institutions (public and private) that offer ICT for health (eHealth) courses
- Tertiary institutions teach students of health sciences about the use of social media for health
- Proportion of tertiary institutions (public and private) that teach students of health sciences about the use of social media for health
- Institutions or associations offer in-service training in the use of ICT for health as part of the continuing education of health professionals
- Proportion of institutions or associations offering in-service training in the use of ICT for health as part of the continuing education of health professionals
- Professional groups that are offered in-service training in the use of ICT for health as part of the continuing education of health professionals
- Institutions or associations offer in-service training in the use of social media for health as part of the continuing education of health professionals
- Professional groups that are offered in-service training in social media for health as part of the continuing education of health professionals
- Access to information and education for health care professionals, using mLearning (operating levels and types of programmes)
- Government-sponsored mHealth programmes exist
- Policies or strategies that guide mHealth programmes
- The role or function of health authorities in respect to the development and adoption of mHealth
- An entity responsible for the regulatory oversight of mobile health apps for quality, safety and reliability exists
- An entity providing incentives and guidance for innovation, research and evaluation of health apps exists
- mHealth programmes for health call centres/health care telephone helpline (operating levels and types)
- mHealth programmes for emergency toll-free telephone services (operating levels and types)
- mHealth programmes for treatment adherence (operating levels and types)
- mHealth programmes for reminders to attend appointments (operating levels and types)
- mHealth programmes for community mobilization/health promotion campaigns (operating levels and types)
- mHealth programmes for mobile telehealth (operating levels and types)
- mHealth programmes for emergencies (operating levels and types)
- mHealth programmes for health surveys (operating levels and types)
- mHealth programmes for surveillance (operating levels and types)
- mHealth programmes for patient monitoring (operating levels and types)
- mHealth programmes that provide access to information resources, databases and tools (operating levels and types)
- mHealth programmes that provide clinical decision support (operating levels and types)
- mHealth programmes that provide access to electronic patient information (operating levels and types)
- The importance of capacity as a barrier to telehealth supporting universal health coverage
- The importance of infrastructure as a barrier to telehealth supporting universal health coverage
- The importance of funding as a barrier to telehealth supporting universal health coverage
- The importance of effectiveness as a barrier to telehealth supporting universal health coverage
- The importance of cost–effectiveness as a barrier to telehealth supporting universal health coverage
- The importance of demand as a barrier to telehealth supporting universal health coverage
- The importance of legal issues as a barrier to telehealth supporting universal health coverage
- The importance of policy as a barrier to telehealth supporting universal health coverage
- The importance of priorities as a barrier to telehealth supporting universal health coverage
- The importance of capacity as a barrier to eLearning supporting universal health coverage
- The importance of infrastructure as a barrier to eLearning supporting universal health coverage
- The importance of funding as a barrier to eLearning supporting universal health coverage
- The importance of limitation as a barrier to eLearning supporting universal health coverage
- The importance of effectiveness as a barrier to eLearning supporting universal health coverage
- The importance of cost–effectiveness as a barrier to eLearning supporting universal health coverage
- The importance of demand as a barrier to eLearning supporting universal health coverage
- The importance of availability as a barrier to eLearning supporting universal health coverage
- The importance of policy as a barrier to eLearning supporting universal health coverage
- The importance of priorities as a barrier to eLearning supporting universal health coverage
- Teleradiology programmes (operating levels and types)
- Teledermatology programmes (operating levels and types)
- Telepathology programmes (operating levels and types)
- Telepsychiatry programmes (operating levels and types)
- Remote patient monitoring programmes (operating levels and types)
- eLearning used to help teach health sciences students in pre-service education
- Main reasons for using eLearning in pre-service education
- Student groups that are offered eLearning as part of their pre-service education
- eLearning usage in health sciences teaching institutions
- Universities offer a health sciences degree that can be gained entirely online
- Universities offer certification in specific health sciences subjects that can be gained entirely online
- eLearning is used for the in-service training of health professionals
- Main reasons for using eLearning for in-service education
- eLearning courses are accredited by continuing medical education (CME) or professional licensing bodies
- National policy or strategy on the use of social media by government organizations makes specific reference to its use in the health domain
- National policy or strategy regulating the use of Big Data in the health sector exists
- National policy or strategy regulating the use of Big Data by private companies exists
- Specific legislation governing the use of the national electronic health record (EHR) system exists
- National policies or legislation to define medical jurisdiction, liability or reimbursement of eHealth services exist
- Policies or legislation exist to address patient safety and quality of care based on data quality, data transmission standards or clinical competency criteria
- Legislation exists to protect the privacy of personally identifiable data of individuals, irrespective of paper or digital formats
- Legislation exists to protect the privacy of individuals' health-related data held in an EHR
- Legislation exists that governs the national sharing of digital data between health professionals in other health services through the use of an EHR
- Legislation exists that governs the international sharing of digital data between health professionals in health services through the use of an EHR
- Legislation exists that allows for the sharing of personal and health data between research entities
- Legislation exists that allows individuals electronic access to their own health-related data when held in an EHR
- Legislation exists that allows individuals to demand their own health-related data be corrected when held in an EHR if it is known to be inaccurate
- Legislation exists that allows individuals to demand the deletion of health-related data from their EHR
- Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice
- The importance of capacity as a barrier to EHR programmes
- The importance of infrastructure as a barrier to EHR programmes
- The importance of funding as a barrier to EHR programmes
- The importance of effectiveness as a barrier to EHR programmes
- The importance of cost–effectiveness as a barrier to EHR programmes
- The importance of demand as a barrier to EHR programmes
- The importance of legal issues as a barrier to EHR programmes
- The importance of policy as a barrier to EHR programmes
- The importance of standards as a barrier to EHR programmes
- The importance of priorities as a barrier to EHR programmes
- The importance of other barriers to EHR programmes
- The importance of standards as a barrier to Big Data supporting universal health coverage
- The importance of information sharing as a barrier to Big Data supporting universal health coverage
- The importance of building capacity as a barrier to Big Data supporting universal health coverage
- The importance of privacy and security as a barrier to Big Data supporting universal health coverage
- The importance of new analytical methods as a barrier to Big Data supporting universal health coverage
- The importance of lack of integration as a barrier to Big Data supporting universal health coverage
- National EHR system exists
- Use of national EHR system by primary care facilities, and proportion using it
- Use of national EHR system by secondary care facilities, and proportion using it
- Use of national EHR system by tertiary care facilities, and proportion using it
- Use of national EHR system by other care facilities, and proportion using it
- Systems linking to national EHR
- International standards used to support the national EHR system
- Electronic medical billing systems used in the health sector
- Supply chain management information systems for health used in the health sector
- Human resources for health information systems used in the health sector
- Professional groups that have adopted eLearning as an approach to in-service training
- Health care organizations use social media to promote health messages as a part of health promotion campaigns
- Health care organizations use social media to help manage patient appointments
- Health care organizations use social media to seek feedback on services
- Health care organizations use social media to make general health announcements
- Health care organizations use social media to make emergency announcements
- Individuals and communities use social media to learn about health issues
- Individuals and communities use social media to help decide on what health services to use
- Individuals and communities use social media to provide feedback to health facilities or health professionals
- Individuals and communities use social media to run community-based health campaigns
- Individuals and communities use social media to participate in community-based health forums
- Eating breakfast
- Eating breakfast, by FAS
- Eating fruit
- Difference in eating fruit, by FAS
- Drinking soft-drinks
- Difference in drinking soft-drinks, by FAS
- Having family meals
- Difference in having family meals, by FAS
- Brushing teeth
- Difference in brushing teeth, by FAS
- Moderate-to-vigorous physical activity
- Difference in moderate-to-vigorous physical activity, by FAS
- Watching television
- Self-rated health
- Life satisfaction
- Health complaints
- Medically attended injuries
- BMI
- Body image
- Weight-reduction behaviour
- Smoking
- Smoking initiation
- Alcohol consumption
- Drunkenness initiation
- Drunkenness
- Cannabis initiation
- Cannabis use lifetime
- Cannabis use last 30 days
- Physical fighting ≥3
- Being bullied
- Bullying others
- Cyber-bullying
- Sexual intercourse
- Condom use
- Birth control pill use
- Talk to mother
- Talk to father
- Family support
- Meet friends before 8 pm
- Social media contact
- Peer support
- Liking school
- School performance
- Pressured by schoolwork
- Classmate support
- Meet friends after 8 pm
- Overweight and obese
- BMI (missing)
- Vigorous physical activity
- Eating vegetables
- Eating sweets
- Drinking wine
- Drinking spirits
- Severe injury
- Physical fighting once
- Difficulties sleeping
- Stomach ache
- Feeling nervous
- Headache
- Feeling low
- Breakfast with family
- Family communication
- Ever smoked
- Smoking daily
- Texting with friends
- Screen time
- Computer games
- Cyber-bullied with picture
- Cyber-bullied with picture several times
- Cyber-bullied mean message
- Been bullied once or twice
- Bullied others once
- Drinking beer
- Drinking alcopops
- Alcohol initiation
- Differences in television watching, by FAS
- Differences in self-rated health, by FAS
- Differences in life satisfaction, by FAS
- Differences in health complaints, by FAS
- Differences in medically attended injuries, by FAS
- Differences in bmi, by FAS
- Differences in body image, by FAS
- Differences in weight-reduction behaviour, by FAS
- Differences in smoking, by FAS
- Differences in smoking initiation, by FAS
- Differences in alcohol consumption, by FAS
- Differences in drunkenness initiation, by FAS
- Differences in drunkenness, by FAS
- Differences in cannabis initiation, by FAS
- Differences in cannabis use lifetime, by FAS
- Differences in cannabis use last 30 days, by FAS
- Differences in physical fighting ≥3, by FAS
- Differences in being bullied, by FAS
- Differences in bullying others, by FAS
- Differences in cyber-bullying, by FAS
- Differences in sexual intercourse, by FAS
- Differences in condom use, by FAS
- Differences in talk to mother, by FAS
- Differences in talk to father, by FAS
- Differences in family support, by FAS
- Differences in meeting friends before 8 pm, by FAS
- Differences in social media contact, by FAS
- Differences in peer support, by FAS
- Differences in liking school, by FAS
- Differences in school performance, by FAS
- Differences in pressured by schoolwork, by FAS
- Differences in classmate support, by FAS
- Family meals together
- Differences in family meals together, by FAS
- Eating breakfast weekend
- Differences in eating breakfast weekend, by FAS
- Differences in eating sweets, by FAS
- Differences in eating vegetables, by FAS
- Vigorous physical activity (timeexe)
- Differences in vigorous physical activity by FAS
- Differences in overweight and obese (IOTF), by FAS
- Thin (IOTF)
- Differences in thin (IOTF), by FAS
- Differences in difficulties in getting to sleep, by FAS
- Differences in feeling low, by FAS
- Differences in feeling nervous, by FAS
- Differences in headache, by FAS
- Differences in stomach ache, by FAS
- Backache
- Differences in backache, by FAS
- Irritable or bad temper
- Differences in irritable or bad temper, by FAS
- Feeling dizzy
- Differences in feeling dizzy, by FAS
- Differences in ever smoked in lifetime, by FAS
- Smoked cigarettes in the last 30d
- Differences in smoked cigarettes in the last 30d, by FAS
- Drunk alcohol in lifetime
- Differences in drunk alcohol in lifetime, by FAS
- Drunk alcohol last 30d
- Differences in drunk alcohol last 30d, by FAS
- Differences in physical fighting once or more, by FAS
- Differences in bullied others once or more, by FAS
- Been cyber bullied once or more
- Differences in been cyber bullied once or more, by FAS
- Cyber bullied others once or more
- Differences in cyber bullied others once or more, by FAS
- Intensive online contact
- Differences in intensive online contact, by FAS
- Preference for online communication
- Differences in preference for online communication, by FAS
- Problematic social media users
- Differences in problematic social media users, by FAS
- Classmate support
- Differences in classmate support, by FAS
- Teacher support
- Differences in teacher support, by FAS
- Premature mortality
- Tobacco smoking
- Tobacco smoking, males
- Tobacco smoking, females
- Alcohol consumption
- Overweight
- Overweight, males
- Overweight, females
- Obesity
- Obesity, males
- Obesity, females
- Measles vaccination
- Polio vaccination
- Mortality from external causes
- Mortality from external causes, males
- Mortality from external causes, females
- Life expectancy
- Life expectancy, males
- Life expectancy, females
- Infant mortality
- Primary school enrolment
- Unemployment
- National health inequities policies
- Life satisfaction
- Social support
- Sanitation
- Sanitation, rural
- Sanitation, urban
- Out-of-pocket expenditures
- Health expenditures
- National target setting
- National policies aligned with Health 2020
- National implementation plans
- National accountability mechanisms
- Primary school enrolment, females
- Premature mortality, males
- Premature mortality, females
- Infant mortality, males
- Infant mortality, females
- Primary school enrolment, males
- Mid-year population
- Mid-year male population
- Mid-year female population
- % of population aged 0–14 years
- % of population aged 0–14 years, males
- % of population aged 0–14 years, females
- % of population aged 65+ years
- % of population aged 65+ years, males
- % of population aged 65+ years, females
- Live births per 1000 population
- Live births per 1000 population, males
- Live births per 1000 population, females
- Number of live births
- Number of live births, males
- Number of live births, females
- Crude death rate per 1000 population
- Crude death rate per 1000 population, males
- Crude death rate per 1000 population, females
- Total fertility rate
- % of urban population
- Average population density per km2
- Area (km2)
- Unemployment rate (%)
- Labour force as % of population
- Annual average rate of inflation (%)
- Gross national income, US$ per capita
- Gross domestic product (GDP), US$ per capita
- Real gross domestic product, PPP$ per capita
- Total government expenditure as % of GDP
- Literacy rate (%) in population aged 15+ years
- Literacy rate (%) in male population aged 15+ years
- Literacy rate (%) in female population aged 15+ years
- % of population with postsecondary education aged 25+ years
- % of population with primary education only aged 25+ years
- % of population with secondary education only aged 25+ years
- UNDP Human Development Index (HDI)
- Life expectancy at birth (years)
- Life expectancy at birth (years), males
- Life expectancy at birth (years), females
- Life expectancy at age 1 (years)
- Life expectancy at age 1 (years), males
- Life expectancy at age 1 (years), females
- Life expectancy at age 15 (years)
- Life expectancy at age 15 (years), males
- Life expectancy at age 15 (years), females
- Life expectancy at age 45 (years)
- Life expectancy at age 45 (years), males
- Life expectancy at age 45 (years), females
- Life expectancy at age 65 (years)
- Life expectancy at age 65 (years), males
- Life expectancy at age 65 (years), females
- Reduction of life expectancy through death before 65 years
- Reduction of life expectancy through death before 65 years, males
- Reduction of life expectancy through death before 65 years, females
- Probability of dying before age 5 per 1000 live births
- Probability of dying before age 5 per 1000 live births, males
- Probability of dying before age 5 per 1000 live births, females
- Estimated probability of dying before age 5, per 1000 live births (world health report)
- Disability-adjusted life expectancy
- Disability-adjusted life expectancy, males
- Disability-adjusted life expectancy, females
- Estimated life expectancy at birth
- Estimated life expectancy at birth, males
- Estimated life expectancy at birth, females
- Estimated infant mortality per 1000 live births (world health report)
- Infant deaths per 1000 live births
- Infant deaths per 1000 live births, males
- Infant deaths per 1000 live births, females
- Neonatal deaths per 1000 live births
- Early neonatal deaths per 1000 live births
- Number of early neonatal deaths
- Late neonatal deaths per 1000 live births
- Postneonatal deaths per 1000 live births
- Fetal deaths per 1000 births
- Number of dead-born fetuses
- Perinatal deaths per 1000 births
- Number of deadborn fetuses with a birth weight of 1000 g or more
- Number of early neonatal deaths with a birth weight of 1000 g or more
- Number of live births with a birth weight of 1000 g or more
- Maternal deaths per 100 000 live births, max of cod and clinical data
- Maternal deaths, abortion, per 100 000 live births
- Maternal deaths, haemorrhage, per 100 000 live births
- Maternal deaths, gestational (pregnancy-induced) hypertension and hyperemesis, per 100 000 live births
- Maternal deaths, puerperium, per 100 000 live births
- Estimated maternal mortality per 100 000 live births (WHO/UNICEFF/UNFPA estimates)
- SDR, diseases of circulatory system, 0–64, per 100 000
- SDR, diseases of circulatory system, 0–64, per 100 000, males
- SDR, diseases of circulatory system, 0–64, per 100 000, females
- SDR, diseases of circulatory system, all ages, per 100 000
- SDR, diseases of circulatory system, all ages, per 100 000, males
- SDR, diseases of circulatory system, all ages, per 100 000, females
- SDR, diseases of circulatory system, 65+, per 100 000
- SDR, diseases of circulatory system, 65+, per 100 000, males
- SDR, diseases of circulatory system, 65+, per 100 000, females
- SDR, ischaemic heart disease, 0–64, per 100 000
- SDR, ischaemic heart disease, 0–64, per 100 000, males
- SDR, ischaemic heart disease, 0–64, per 100 000, females
- SDR, ischaemic heart disease, all ages, per 100 000
- SDR, ischaemic heart disease, all ages, per 100 000, males
- SDR, ischaemic heart disease, all ages, per 100 000, females
- SDR, ischaemic heart disease, 65+, per 100 000
- SDR, ischaemic heart disease, 65+, per 100 000, males
- SDR, ischaemic heart disease, 65+, per 100 000, females
- SDR, cerebrovascular diseases, 0–64, per 100 000
- SDR, cerebrovascular diseases, 0–64, per 100 000, males
- SDR, cerebrovascular diseases, 0–64, per 100 000,females
- SDR, cerebrovascular diseases, all ages, per 100 000
- SDR, cerebrovascular diseases, all ages, per 100 000, males
- SDR, cerebrovascular diseases, all ages, per 100 000, females
- SDR, cerebrovascular diseases, 65+, per 100 000
- SDR, cerebrovascular diseases, 65+, per 100 000, males
- SDR, cerebrovascular diseases, 65+, per 100 000, females
- SDR, malignant neoplasms, 0–64, per 100 000
- SDR, malignant neoplasms, 0–64, per 100 000, males
- SDR, malignant neoplasms, 0–64, per 100 000, females
- SDR, malignant neoplasms, all ages, per 100 000
- SDR, malignant neoplasms, all ages, per 100 000, males
- SDR, malignant neoplasms, all ages, per 100 000, females
- SDR, malignant neoplasms, 65+, per 100 000
- SDR, malignant neoplasms, 65+, per 100 000, males
- SDR, malignant neoplasms, 65+, per 100 000, females
- SDR, trachea/bronchus/lung cancer, 0–64, per 100 000
- SDR, trachea/bronchus/lung cancer, 0–64, per 100 000, males
- SDR, trachea/bronchus/lung cancer, 0–64, per 100 000, females
- SDR, trachea/bronchus/lung cancer, all ages, per 100 000
- SDR, trachea/bronchus/lung cancer, all ages, per 100 000, males
- SDR, trachea/bronchus/lung cancer, all ages, per 100 000, females
- SDR, trachea/bronchus/lung cancer, 65+, per 100 000
- SDR, trachea/bronchus/lung cancer, 65+, per 100 000, males
- SDR, trachea/bronchus/lung cancer, 65+, per 100 000, females
- SDR, cancer of the cervix uteri, 0–64, per 100 000
- SDR, cancer of the cervix uteri, all ages, per 100 000
- SDR, cancer of the cervix uteri, 65+, per 100 000
- SDR, malignant neoplasm female breast, 0–64, per 100 000
- SDR, malignant neoplasm female breast, all ages, per 100 000
- SDR, malignant neoplasm female breast, 65+, per 100 000
- SDR, external causes of injury and poisoning, 0–64, per 100 000
- SDR, external causes of injury and poisoning, 0–64, per 100 000, males
- SDR, external causes of injury and poisoning, 0–64, per 100 000, females
- SDR, external causes of injury and poisoning, 0–4
- SDR, external causes of injury and poisoning, 0–4, males
- SDR, external causes of injury and poisoning, 0–4, females
- SDR, external causes of injury and poisoning, 5–19
- SDR, external causes of injury and poisoning, 5–19, males
- SDR, external causes of injury and poisoning, 5–19, females
- SDR, external causes of injury and poisoning, all ages, per 100 000
- SDR, external causes of injury and poisoning, all ages, per 100 000, males
- SDR, external causes of injury and poisoning, all ages, per 100 000, females
- SDR, external causes of injury and poisoning, 65+, per 100 000
- SDR, external causes of injury and poisoning, 65+, per 100 000, males
- SDR, external causes of injury and poisoning, 65+, per 100 000, females
- SDR, motor vehicle traffic accidents, 0–64, per 100 000
- SDR, motor vehicle traffic accidents, 0–64, per 100 000, males
- SDR, motor vehicle traffic accidents, 0–64, per 100 000, females
- SDR, motor vehicle traffic accidents, all ages, per 100 000
- SDR, motor vehicle traffic accidents, all ages, per 100 000, males
- SDR, motor vehicle traffic accidents, all ages, per 100 000, females
- SDR, motor vehicle traffic accidents, 65+, per 100 0000
- SDR, motor vehicle traffic accidents, 65+, per 100 000, males
- SDR, motor vehicle traffic accidents, 65+, per 100 000, females
- SDR, suicide and self-inflicted injury, 0–64, per 100 000
- SDR, suicide and self-inflicted injury, 0–64, per 100 000, males
- SDR, suicide and self-inflicted injury, 0–64, per 100 000, females
- SDR, suicide and self-inflicted injury, all ages, per 100 000
- SDR, suicide and self-inflicted injury, all ages, per 100 000, males
- SDR, suicide and self-inflicted injury, all ages, per 100 000, females
- SDR, suicide and self-inflicted injury, 65+, per 100 000
- SDR, suicide and self-inflicted injury, 65+, per 100 000, males
- SDR, suicide and self-inflicted injury, 65+, per 100 000, females
- SDR, homicide and intentional injury, 0–64, per 100 000
- SDR, homicide and intentional injury, 0–64, per 100 000, males
- SDR, homicide and intentional injury, 0–64, per 100 000, females
- SDR, homicide and intentional injury, all ages, per 100 000
- SDR, homicide and intentional injury, all ages, per 100 000, males
- SDR, homicide and intentional injury, all ages, per 100 000, females
- SDR, homicide and intentional injury, 65+, per 100 000
- SDR, homicide and intentional injury, 65+, per 100 000, males
- SDR, homicide and intentional injury, 65+, per 100 000, females
- SDR, transport accidents, all ages, per 100 000
- SDR, transport accidents, all ages, per 100 000, males
- SDR, transport accidents, all ages, per 100 000, females
- SDR all causes, all ages, per 100 000
- SDR, all causes, all ages, per 100 000, males
- SDR, all causes, all ages, per 100 000, females
- SDR, all causes, 0–64, per 100 000
- SDR, all causes, 0–64, per 100 000, males
- SDR, all causes, 0–64, per 100 000, females
- SDR, all causes, 65+, per 100 000
- SDR, all causes, 65+, per 100 000, males
- SDR, all causes, 65+, per 100 000, females
- SDR, infectious and parasitic diseases, all ages, per 100 000
- SDR, infectious and parasitic diseases, all ages, per 100 000, males
- SDR, infectious and parasitic diseases, all ages, per 100 000, females
- SDR, infectious and parasitic diseases, 0–64, per 100 000
- SDR, infectious and parasitic diseases, 0–64, per 100 000, males
- SDR, infectious and parasitic diseases, 0–64, per 100 000, females
- SDR, infectious and parasitic diseases, 65+, per 100 000
- SDR, infectious and parasitic diseases, 65+, per 100 000, males
- SDR, infectious and parasitic diseases, 65+, per 100 000, females
- SDR, diseases of respiratory system, all ages, per 100 000
- SDR, diseases of respiratory system, all ages, per 100 000, males
- SDR, diseases of respiratory system, all ages, per 100 000, females
- SDR, diseases of respiratory system, 0–64, per 100 000
- SDR, diseases of respiratory system, 0–64, per 100 000, males
- SDR, diseases of respiratory system, 0–64, per 100 000, females
- SDR, diseases of respiratory system, 65+, per 100 000
- SDR, diseases of respiratory system, 65+, per 100 000, males
- SDR, diseases of respiratory system, 65+, per 100 000, females
- SDR, bronchitis/emphysema/asthma, all ages, per 100 000
- SDR, bronchitis/emphysema/asthma, all ages, per 100 000, males
- SDR, bronchitis/emphysema/asthma, all ages, per 100 000, females
- SDR, bronchitis/emphysema/asthma, 0–64, per 100 000
- SDR, bronchitis/emphysema/asthma, 0–64, per 100 000, males
- SDR, bronchitis/emphysema/asthma, 0–64, per 100 000, females
- SDR, diseases of digestive system, all ages, per 100 000
- SDR, diseases of digestive system, all ages, per 100 000, males
- SDR, diseases of digestive system, all ages, per 100 000, females
- SDR, diseases of digestive system, 0–64, per 100 000
- SDR, diseases of digestive system, 0–64, per 100 000, males
- SDR, diseases of digestive system, 0–64, per 100 000, females
- SDR, diseases of digestive system, 65+, per 100 000
- SDR, diseases of digestive system, 65+, per 100 000, males
- SDR, diseases of digestive system, 65+, per 100 000, females
- SDR, chronic liver disease and cirrhosis, all ages, per 100 000
- SDR, chronic liver disease and cirrhosis, all ages, per 100 000, males
- SDR, chronic liver disease and cirrhosis, all ages, per 100 000, females
- SDR, chronic liver disease and cirrhosis, 0–64, per 100 000
- SDR, chronic liver disease and cirrhosis, 0–64, per 100 000, males
- SDR, chronic liver disease and cirrhosis, 0–64, per 100 000, females
- SDR, endocrine, nutritional and metabolic diseases, all ages, per 100 000
- SDR, endocrine/nutrition/metabolic disease/disorder involving immune mechanism, all ages, per 100 000, males
- SDR, endocrine/nutrition/metabolic disease/disorder involving immune mechanism, all ages, per 100 000, females
- SDR, endocrine/nutrition/metabolic disease/disorder involving immune mechanism, 0–64, per 100 000
- SDR, endocrine/nutrition/metabolic disease/disorder involving immune mechanism, 0–64, per 100 000, males
- SDR, endocrine/nutrition/metabolic disease/disorder involving immune mechanism, 0–64, per 100 000, females
- SDR, diabetes, all ages, per 100 000
- SDR, diabetes mellitus, all ages, per 100 000, males
- SDR, diabetes mellitus, all ages, per 100 000, females
- SDR, diabetes mellitus, 0–64, per 100 000
- SDR, diabetes mellitus, 0–64, per 100 000, males
- SDR, diabetes mellitus, 0–64, per 100 000, females
- SDR, diseases of the blood, blood forming organs and certain immunity disorders, all ages, per 100 000
- SDR, diseases of the blood, blood forming organs and certain immunity disorders, all ages, per 100 000, males
- SDR, diseases of the blood, blood forming organs and certain immunity disorders, all ages, per 100 000, females
- SDR, diseases of the blood, blood forming organs and certain immunity disorders, 0–64, per 100 000
- SDR, diseases of the blood, blood forming organs and certain immunity disorders, 0–64, per 100 000, males
- SDR, diseases of the blood, blood forming organs and certain immunity disorders, 0–64, per 100 000, females
- SDR, mental disorders, diseases of nervous system and sense organs, all ages, per 100 000
- SDR, mental disorders, diseases of nervous system and sense organs, all ages, per 100 000, males
- SDR, mental disorders, diseases of nervous system and sense organs, all ages, per 100 000, females
- SDR, mental disorders, diseases of nervous system and sense organs, 0–64, per 100 000
- SDR, mental disorders, diseases of nervous system and sense organs, 0–64, per 100 000, males
- SDR, mental disorders, diseases of nervous system and sense organs, 0–64, per 100 000, females
- SDR, mental disorders, diseases of nervous system and sense organs, 65+/100 000
- SDR, mental disorders, diseases of nervous system and sense organs, 65+/100 000, males
- SDR, mental disorders, diseases of nervous system and sense organs, 65+/100 000, females
- SDR, disease of genitourinary system, all ages, per 100 000
- SDR, disease of genitourinary system, all ages, per 100 000, males
- SDR, disease of genitourinary system, all ages, per 100 000, females
- SDR, disease of genitourinary system, 0–64, per 100 000
- SDR, disease of genitourinary system, 0–64, per 100 000, males
- SDR, disease of genitourinary system, 0–64, per 100 000, females
- SDR, symptoms, signs and ill-defined conditions, all ages, per 100 000
- SDR, symptoms, signs and ill defined conditions, all ages, per 100 000, males
- SDR, symptoms, signs and ill defined conditions, all ages, per 100 000, females
- SDR, symptoms, signs and ill defined conditions, 0–64, per 100 000
- SDR, symptoms, signs and ill defined conditions, 0–64, per 100 000, males
- SDR, symptoms, signs and ill defined conditions, 0–64, per 100 000, females
- SDR, symptoms, signs and ill defined conditions, 65+, per 100 000
- SDR, symptoms, signs and ill defined conditions, 65+, per 100 000, males
- SDR, symptoms, signs and ill defined conditions, 65+, per 100 000, females
- SDR, tuberculosis, all ages, per 100 000
- SDR, tuberculosis, all ages, per 100 000, males
- SDR, tuberculosis, all ages, per 100 000, females
- SDR, diarrhoeal diseases, under 5 years, per 100 000
- SDR, diarrhoeal diseases, under 5 years, per 100 000, males
- SDR, diarrhoeal diseases, under 5 years, per 100 000, females
- SDR, acute respiratory infections, pneumonia and influenza, under 5 years, per 100 000
- SDR, acute respiratory infections, pneumonia and influenza, under 5 years, per 100 000, males
- SDR, acute respiratory infections, pneumonia and influenza, under 5 years, per 100 000, females
- SDR, selected alcohol-related causes, per 100 000
- SDR, selected alcohol-related causes, per 100 000, males
- SDR, selected alcohol-related causes, per 100 000, females
- SDR, selected smoking-related causes, per 100 000
- SDR, selected smoking-related causes, per 100 000, males
- SDR, selected smoking-related causes, per 100 000, females
- Incidence of tuberculosis per 100 000
- Number of new tuberculosis cases
- Estimated incidence of tuberculosis per 100 000
- Estimated prevalence of tuberculosis per 100 000
- Estimated mortality of tuberculosis per 100 000
- Proportion (%) of tuberculosis cases detected under DOTS
- Proportion (%) of tuberculosis cases cured under DOTS
- Incidence of viral hepatitis per 100 000
- Number of new viral hepatitis cases
- Number of new hepatitis C cases
- Incidence of hepatitis C per 100 000
- Incidence of viral hepatitis A per 100 000
- Number of new hepatitis A cases
- Incidence of viral hepatitis B per 100 000
- Number of new hepatitis B cases
- Incidence of syphilis per 100 000
- Number of new syphilis cases
- Incidence of gonococcal infection per 100 000
- Number of new gonococcal infection cases
- Incidence of pertussis per 100 000
- Number of new pertussis cases
- Incidence of measles per 100 000
- Number of new measles cases
- Incidence of malaria per 100 000
- Number of new malaria cases
- Number of deaths from malaria
- Incidence of diphtheria per 100 000
- Number of new diphtheria cases
- Incidence of tetanus per 100 000
- Number of new tetanus cases
- Incidence of acute poliomyelitis per 100 000
- Number of new poliomyelitis cases
- Incidence of congenital syphilis per 100 000
- Number of new congenital syphilis cases
- Incidence of congenital rubella per 100 000
- Number of new congenital rubella cases
- Incidence of neonatal tetanus per 100 000
- Number of new neonatal tetanus cases
- Incidence of rubella per 100 000
- Number of new rubella cases
- Incidence of mumps per 100 000
- Number of new mumps cases
- Rate of new AIDS cases per 100 000
- Number of new AIDS cases
- Rate of new HIV diagnoses per 100 000
- Number of new HIV diagnoses
- Incidence of Haemophilus influenzae type b invasive disease per 100 000
- Number of new Haemophilus influenzae type b invasive disease cases
- Hospital discharges, infectious and parasitic diseases per 100 000
- Hospital discharges, infectious and parasitic diseases
- Hospital discharges, all neoplasms per 100 000
- Hospital discharges, all neoplasms
- Incidence of cancer per 100 000
- Number of new cases of cancer
- Number of new cases of cancer, males
- Number of new cases of cancer, females
- Incidence of cancer per 100 000, males
- Incidence of cancer per 100 000, female
- Prevalence of cancer (%)
- Number of all cases of cancer at year's end
- Number of all cases cancer at year's end, males
- Number of all cases cancer at year's end, females
- Prevalence of cancer (%), males
- Prevalence of cancer (%), females
- Incidence of trachea, bronchus and lung cancer per 100 000
- Number of new cases of trachea, bronchus and lung cancer
- Number of new cases of trachea, bronchus and lung cancer, males
- Number of new cases of trachea, bronchus and lung cancer, females
- Incidence of trachea, bronchus and lung cancer per 100 000, males
- Incidence of trachea, bronchus and lung cancer per 100 000, females
- Incidence of female breast cancer per 100 000
- Number of new cases of female breast cancer
- Incidence of cervix uteri cancer per 100 000
- Number of new cases of cervix uteri cancer
- Prevalence of diabetes mellitus (%)
- Number of all cases of diabetes mellitus at year's end
- Number of new cases of diabetes mellitus
- New cases, diabetes mellitus per 100 000
- Number of mental patients staying in hospitals 365+ days per 100 000
- Number of mental patients staying in hospitals 365+ days
- Number of hospital discharges, mental and behavioural disorders
- Hospital discharges, mental and behavioural disorders, per 100 000
- Incidence of mental disorders per 100 000
- Number of new cases of mental disorders
- Incidence of alcoholic psychosis per 100 000
- Number of new cases of alcoholic psychosis
- Prevalence of mental disorders (%)
- All cases of mental disorders at year's end
- Hospital discharges, circulatory system disease, per 100 000
- Number of hospital discharges, circulatory system disease
- Hospital discharges, ischaemic heart disease, per 100 000
- Number of hospital discharges, ischaemic heart disease
- Hospital discharges, cerebrovascular diseases, per 100 000
- Hospital discharges, cerebrovascular diseases
- Hospital discharges, respiratory system diseases, per 100 000
- Hospital discharges, respiratory system diseases
- Prevalence of chronic obstructive pulmonary disease (%)
- Number of cases of chronic obstructive pulmonary disease
- Hospital discharges, digestive system diseases, per 100 000
- Hospital discharges, digestive system diseases
- Hospital discharges, musculoskeletal system and connective tissue diseases, per 100 000
- Hospital discharges, musculoskeletal system and connective tissue diseases
- Hospital discharges, injury and poisoning, per 100 000
- Hospital discharges, injury and poisoning
- Absenteeism from work due to illness, days per employee per year
- New invalidity/disability cases per 100 000
- Number of newly recognized invalidity/disability cases
- People receiving social/disability benefits per 100 000
- Number of people receiving social/disability benefits
- % of disabled people of working age engaged in regular occupational activity
- % population self-assessing health as good
- % population self-assessing health as good, males
- % population self-assessing health as good, females
- % of regular daily smokers in the population, age 15+
- % of regular daily smokers in the population, age 15+, males
- % of regular daily smokers in the population, age 15+, females
- Pure alcohol consumption, litres per capita, age 15+
- Spirits consumed in pure alcohol, litres per capita, age 15+
- Wine consumed in pure alcohol, litres per capita, age 15+
- Beer consumed in pure alcohol, litres per capita, age 15+
- Road traffic accidents involving alcohol per 100 000
- Number of road traffic accidents involving alcohol
- First admissions to drug treatment centres per 100 000
- Number of first admissions to drug treatment centres
- Road traffic accidents with injury per 100 000
- Number of road traffic accidents with injury
- People killed or injured in road traffic accidents per 100 000
- Number of people killed or injured in road traffic accidents
- Average number of calories available per person per day (kcal)
- % of total energy available from fat
- Fat available per person per day (g)
- % of total energy available from protein
- Protein available per person per day (g)
- Average amount of cereal available per person per year (kg)
- Average amount of fruits and vegetables available per person per year (kg)
- Microbiological foodborne diseases, number of outbreaks
- Microbiological foodborne diseases per 100 000
- Number of cases of microbiological foodborne diseases
- Salmonellosis cases per 100 000
- Number of salmonellosis cases
- New cases of occupational diseases per 100 000
- Number of new cases of occupational diseases
- People injured due to work-related accidents per 100 000
- Number of people injured due to work-related accidents
- Deaths due to work-related accidents per 100 000
- Number of deaths due to work-related accidents
- % population with homes connected to water supply system
- % population with homes connected to water supply system, urban
- % population with homes connected to water supply system, rural
- % population with access to sewage system, septic tank or other hygienic means of sewage disposal
- % population with access to sewage system, septic tank or other hygienic means of sewage disposal, urban
- % population with access to sewage system, septic tank or other hygienic means of sewage disposal, rural
- Average number of people per room in occupied housing unit
- Hospitals per 100 000
- Number of hospitals
- Acute (short-stay) hospitals per 100 000
- Number of acute (short-stay) hospitals
- Primary health care units per 100 000
- Number of primary health care units
- Hospital beds per 100 000
- Total number of hospital beds
- Acute care hospital beds per 100 000
- Number of acute care hospital beds
- Acute care hospital beds, medical group of specialties
- Acute care hospital beds, medical group of specialties, per 100 000
- Acute care hospital beds, surgical group of specialties
- Acute care hospital beds, surgical group of specialties, per 100 000
- Acute care hospital beds, obstetric and gynaecological group of specialties
- Acute care hospital beds, obstetric and gynaecological group of specialties, per 100 000
- Acute care hospital beds, paediatric group of specialties
- Acute care hospital beds, paediatric group of specialties, per 100 000
- Psychiatric hospital beds per 100 000
- Number of psychiatric hospital beds
- Nursing and elderly home beds per 100 000
- Number of nursing and elderly home beds
- Private inpatient hospital beds as % of all beds
- Number of private inpatient hospital beds
- Physicians per 100 000
- Number of physicians, physical persons (PP)
- Physicians, full-time equivalent (FTE) per 100 000
- Number of physicians, full-time equivalent (FTE)
- Physicians, medical group of specialties (PP), per 100 000
- Number of physicians, medical group of specialties (PP)
- Number of physicians, surgical group of specialties (PP)
- Physicians, surgical group of specialties (PP), per 100 000
- Number of physicians, obstetric and gynaecological group of specialties (PP)
- Physicians, obstetric and gynaecological group of specialties (PP), per 100 000
- Number of physicians, paediatric specialties (PP)
- Physicians, paediatric group of specialties (PP), per 100 000
- % of physicians working in hospitals
- General practitioners (PP) per 100 000
- Number of general practitioners (PP)
- Dentists (PP) per 100 000
- Number of dentists (PP)
- Dentists (FTE) per 100 000
- Number of dentists (FTE)
- Pharmacists (PP) per 100 000
- Number of pharmacists (PP)
- Nurses (PP) per 100 000
- Number of nurses (PP)
- Nurses (FTE) per 100 000
- Number of nurses (FTE)
- % of nurses working in hospitals
- Midwives (PP) per 100 000
- Number of midwives (PP)
- Midwives (FTE) per 100 000
- Number of midwives (FTE)
- Physicians graduated per 100 000
- Number of physicians graduated in given year
- Nurses graduated per 100 000
- Number of nurses graduated in given year
- Midwives graduated per 100 000
- Number of midwives graduated in given year
- Pharmacists graduated per 100 000
- Number of pharmacists graduated in given year
- Dentists graduated per 100 000
- Number of dentists graduated in given year
- Inpatient care discharges per 100
- Number of all hospital discharges
- Acute care hospital discharges per 100
- Number of acute care hospital discharges
- Inpatient surgical procedures per year per 100 000
- Total number of inpatient surgical procedures per year
- Average length of stay, all hospitals
- Average length of stay, acute care hospitals only
- Bed occupancy rate (%), acute care hospitals only
- Outpatient contacts per person per year
- Autopsy rate (%) for hospital deaths
- Autopsy rate (%) for all deaths
- Surgical wound infection rate (%), all operations
- SDR, appendicitis, 0–64, per 100 000
- SDR, appendicitis, 0–64, per 100 000, males
- SDR, appendicitis, 0–64, per 100 000, females
- SDR, appendicitis, all ages, per 100 000
- SDR, appendicitis, all ages, per 100 000, males
- SDR, appendicitis, all ages, per 100 000, females
- SDR, hernia and intestinal obstruction, 0–64, per 100 000
- SDR, hernia and intestinal obstruction, 0–64, per 100 000, males
- SDR, hernia and intestinal obstruction, 0–64, per 100 000, females
- SDR, hernia and intestinal obstruction, all ages, per 100 000
- SDR, hernia and intestinal obstruction, all ages, per 100 000, males
- SDR, hernia and intestinal obstruction, all ages, per 100 000, females
- SDR, adverse effects of therapeutic agents, 0–64, per 100 000
- SDR, adverse effects of therapeutic agents, 0–64, per 100 000, males
- SDR, adverse effects of therapeutic agents, 0–64, per 100 000, females
- SDR, adverse effects of therapeutic agents, all ages, per 100 000
- SDR, adverse effects of therapeutic agents, all ages, per 100 000, males
- SDR, adverse effects of therapeutic agents, all ages, per 100 000, females
- Total health expenditure as % of GDP, WHO estimates
- Total health expenditure as % of GDP
- Public-sector expenditure on health as % of GDP, WHO estimates
- Private-sector expenditure on health as % of GDP, WHO estimates
- Total health expenditure, PPP$ per capita, WHO estimates
- Total health expenditure, PPP$ per capita
- Public expenditure on health, PPP$ per capita, WHO estimates
- Public-sector health expenditure as % of total health expenditure, WHO estimates
- Public-sector health expenditure as % of total health expenditure
- Private-sector expenditure on health as % of total health expenditure, WHO estimates
- Total inpatient expenditure as % of total health expenditure
- Public inpatient expenditure as % of total inpatient expenditure
- Total pharmaceutical expenditure as % of total health expenditure
- Public pharmaceutical expenditure as % of total pharmaceutical expenditure
- Total capital investment expenditure on medical facilities as % of total health expenditure
- Salaries as % of total public health expenditure
- Public-sector expenditure on health as % of total government expenditure, WHO estimates
- Private households' out-of-pocket payments on health as % of total health expenditure
- Private households' out-of-pocket payments on health as % of private-sector health expenditure
- Abortions per 1000 live births
- Number of abortions, all ages
- Abortions per 1000 live births, age under 20 years
- Number of abortions, age under 20 years
- Abortions per 1000 live births, age 35+ years
- Number of abortions, age 35+ years
- % of all live births to mothers aged under 20 years
- Number of all live births to mothers aged under 20 years
- % of all live births to mothers aged 35+ years
- Number of all live births, mothers aged 35+ years
- Caesarean sections per 1000 live births
- Number of caesarean sections
- Proportion (%) of births attended by skilled health personnel
- Contraceptive use among currently married women aged 15–49 (%), any method
- % of live births weighing 2500 g or more
- Congenital anomalies per 100 000 live births
- Number of births with congenital anomalies
- Births with Down's syndrome per 100 000 live births
- Number of births with Down's syndrome
- % of infants vaccinated against tuberculosis
- % of infants vaccinated against diphtheria
- % of infants vaccinated against tetanus
- % of infants vaccinated against pertussis
- % of children vaccinated against measles
- % of infants vaccinated against poliomyelitis
- % infants vaccinated against invasive disease due to Haemophilus influenzae type b
- % of infants vaccinated against hepatitis B
- % of infants vaccinated against mumps
- % of infants vaccinated against rubella
- % of infants breastfed at age 3 months
- % of infants breastfed at age 6 months
- GINI coefficient (income distribution)
- Proportion of children of official primary school age not enrolled, both sexes
- Proportion of children of official primary school age not enrolled, males
- Proportion of children of official primary school age not enrolled, females
- Availability of social support
- Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, WHO estimates (%)
- Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, WHO estimates (%), males
- Age-standardized prevalence of current tobacco smoking among people aged 15 years and over, WHO estimates (%), females
- Number cigarettes consumed per person per year
- Total number of cigarettes consumed (in million pieces), per year
- Age-standardized prevalence of overweight (defined as BMI = 25 kg/m2) in people aged 18 years and over, WHO estimates (%)
- Age-standardized prevalence of overweight (defined as BMI = 25 kg/m2) in people aged 18 years and over, WHO estimates (%), males
- Age-standardized prevalence of overweight (defined as BMI = 25 kg/m2) in people aged 18 years and over, WHO estimates (%), females
- Age-standardized prevalence of obesity (defined as BMI = 30 kg/m2) in people aged 18 years and over, WHO estimates (%)
- Age-standardized prevalence of obesity (defined as BMI = 30 kg/m2) in people aged 18 years and over, WHO estimates (%), males
- Age-standardized prevalence of obesity (defined as BMI = 30 kg/m2) in people aged 18 years and over, WHO estimates (%), females
- Perinatal deaths national criteria per 1000 births
- Perinatal deaths 1000+g per 1000 births
- Maternal deaths per 100 000 live births according to clinical data
- Maternal deaths, cause of death data per 100 000 live births
- SDR, major non-communicable diseases, 30-69 years, both sexes
- SDR, major noncommunicable diseases, 30-69 years, males
- SDR, major noncommunicable diseases, 30-69 years, females
- SDR, digestive diseases, 30-69 years, both sexes
- SDR, digestive diseases, 30-69 years, males
- SDR, digestive diseases, 30-69 years, females
- Members of the European Health Information Initiative
- Healthy life expectancy (HALE ) at birth, female
- Healthy life expectancy (HALE) at birth, male
- Healthy life expectancy (HALE) at birth
- Youth unemployment rate, % of total labor force ages 15-24
- Youth unemployment rate, % of labor force ages 15-24, female
- Youth unemployment rate, % of labor force ages 15-24, male
- Number of maternal deaths, clinical data
- Number of reported outbreaks of diseases arising from drinking-water
- Number of reported episodes of illness attributable to diseases carried in drinking-water
- Population with house connections to piped water
- Population connected to wastewater treatment facilities
- Population with home connection to improved sanitation facilities
- Bathing water quality for coastal zones in EU countries, levels of compliance
- Bathing water quality for freshwater zones in EU countries
- Standardized death rates (three-year average) for road traffic injuries in people aged 0–24 years
- Standardized road traffic injury rates in people aged 0–24 years
- Numbers of people aged 0–24 years injured in road traffic accidents per 100 000 motor vehicles
- Deaths from unintentional injuries by cause in the age group 0–19 years
- Standardized death rates for unintentional injuries in the age group 1–19 years - drowning and submersion
- Standardized death rates unintentional injuries in the age group 1–19 years - poisoning
- Standardized death rates unintentional injuries in the age group 1–19 years - accidental falls
- Standardized death rates unintentional injuries in the age group 1–19 years - exposure to smoke, fire and flames
- Prevalence of overweight (including obesity) among 11-year-olds
- Prevalence of overweight (including obesity) among 13-year-olds
- Prevalence of overweight (including obesity) among 15-year-olds
- Percentages of physically active children among 11-year-olds
- Percentages of physically active children among 13-year-olds
- Percentages of physically active children among 15-year-olds
- Post-neonatal infant death rates due to respiratory diseases
- Percentage of people living in cities with various PM10 levels in μg/m3
- Population weighted annual mean PM10 in cities
- Population weighted annual mean PM2.5 in cities
- Proportion of 13–15-year-olds exposed to SHS inside and outside the home
- Proportion of 15-year-old children smoking daily
- Proportion of 13-year-old children smoking daily
- Proportion of 11-year-old children smoking daily
- Proportion of the total population living in homes with self-reported problems of damp
- Proportion of population in relative poverty living in homes with self-reported problems of damp
- Percentages of children aged 0−14 years living in homes using solid fuels for cooking
- Proportion of countries implementing policies to re-duce exposure of children to SHS
- Degree of implementation of policies to reduce exposure of children to SHS
- Population weighted annual mean SOMO35 in cities
- Estimates of age-standardized incidence of leukaemia in children aged under 15 years
- Age-standardized incidence of melanoma in people aged under 55 years
- Time trends of melanoma incidence in Norway, Sweden and Iceland
- Dioxin levels in human milk in selected countries
- POPs levels in human milk, Sweden
- Heavy metal intake through food by adults
- Mean level of selected hazardous metals in the total diet of the general population of the Czech Republic
- Mean blood lead levels of children measured in areas without significant local sources of lead exposure
- Estimated mean radon levels in dwellings
- Standardized incidence of work injuries among employees aged under 18 years
- Standardized incidence of work injuries among employees aged 18-24 years
- Percentage of urban population exposed to noise level Lden > 55 dB
- Percentage of urban population exposed to noise level Lnight > 50 dB
- Percentage of population reporting that noise is a problem in the living environment
- Level of DDT pollutant concentration in human milk
- Level of PCB pollutant concentration in human milk
- Level of HCB pollutant concentration in human milk
- Level of PCN pollutant concentration in human milk
- Level of PBDE pollutant concentration in human milk
- Level of total concentrations for pollutants in human milk expressed in WHO toxic equivalents (WHO-TEQs)
- Immigrant population
- People at risk of poverty or social exclusion
- Generalist medical practitioners, per 100 000 population
- General paediatricians, per 100 000 population
- Practicing nurses, per 100 000 population
- Minimum age of criminal responsibility
- Public places included in national smoke-free legislation
- Overweight and obese (11, 13, 15 years)
- Moderate to vigorous physical activity
- Soft drink consumption (11, 13, 15 years)
- Brushing Teeth (11, 13, 15 years)
- Condom use at last intercourse (15 years old)
- PCV vaccine coverage
- Rotavirus vaccine coverage
- Estimated child HIV rates
- Adolescent HIV rates (15-24 years)
- ORT for diarrhoea with continued feeding, children under 5
- Overweight and obese (6-9 years old)
- Potential criminal liability for children
- Population aged 0–14 years
- Associate nurses employed by hospital in FTE, per 10 000 population
- Associate professional nurses employed by hospital, head count
- Medical doctors not further defined, per 10 000 population
- Associate nurses employed by hospital in FTE, total number
- Associate professional nurses employed by hospital, per 10 000 population
- Associate professional nurses, licensed to practice, per 10 000 population
- Associate professional nurses, licensed to practice, head count
- Associate professional nurses, practising, per 10 000 population
- Associate professional nurses, practising, head count
- Associate professional nurses, professionally active, per 10 000 population
- Associate professional nurses, professionally active, head count
- Associate professional nursing graduates, per 10 000 population
- Associate professional nursing graduates, head count
- Dentists graduates, per 10 000 population
- Dentists graduates, head count
- Dentists licensed to practice, per 10 000 population
- Dentists licensed to practice, head count
- Generalist medical practitioners, per 10 000 population
- Generalist medical practitioners, head count
- General paediatricians, per 10 000 population
- General paediatricians, head count
- General practitioners, per 10 000 population
- General practitioners, head count
- Health care assistants employed by hospital in FTE, per 10 000 population
- Health care assistants employed by hospital in FTE, total number
- Health care assistants employed by hospital, per 10 000 population
- Health care assistants employed by hospital, head count
- Medical doctors not further defined, head count
- Medical graduates, per 10 000 population
- Medical graduates, head count
- Medical group of specialists, per 10 000 population
- Medical group of specialists, head count
- Midwives graduates, per 10 000 population
- Midwives graduates, head count
- Midwives licensed to practice, per 10 000 population
- Midwives licensed to practice, head count
- Nurses and midwives employed by hospital, per 10 000 population
- Nurses and midwives employed by hospital, head count
- Nurses licensed to practice, per 10 000 population
- Total nurses licensed to practice, head count
- Nursing graduates, per 10 000 population
- Nursing graduates, head count
- Obstetricians and gynaecologists, per 10 000 population
- Obstetricians and gynaecologists, head count
- % of physicians, both sexes, 35–44 years old
- % of physicians, both sexes, 45–54 years old
- % of physicians, both sexes, 55–64 years old
- % of physicians, both sexes, 65 years old or older
- % of physicians by sex, all ages
- % of physicians, both sexes, younger than 35 years
- Other generalist (non–specialist) medical practitioners, per 10 000 population
- Other generalist (non–specialist) medical practitioners, head count
- Other health service providers employed by hospital in FTE, per 10 000 population
- Other health service providers employed by hospital in FTE, total number
- Other health service providers employed by hospital, per 10 000 population
- Other health service providers employed by hospital, head count
- Other specialists not elsewhere classified, per 10 000 population
- Other specialists not elsewhere classified, head count
- Other staff employed by hospital in FTE, per 10 000 population
- Other staff employed by hospital in FTE, total number
- Other staff employed by hospital, per 10 000 population
- Other staff employed by hospital, head count
- Pharmacists graduates, per 10 000 population
- Pharmacists graduates, head count
- Pharmacists licensed to practice, per 10 000 population
- Pharmacists licensed to practice, head count
- Physicians, both sexes, 35–44 years old
- Physicians, both sexes, 45–54 years old
- Physicians, both sexes, 55–64 years old
- Physicians, both sexes, 65 years old or older
- Physicians, both sexes, all ages
- Physicians employed by hospital in FTE, per 10 000 population
- Physicians employed by hospital in FTE, total number
- Physicians employed by hospital, per 10 000 population
- Physicians employed by hospital, head count
- Physicians licensed to practice, per 10 000 population
- Physicians licensed to practice, head count
- Physicians, both sexes, younger than 35 years
- Population used as denominator, both sexes
- Social care workers (personal care workers), practicing per 10 000 population
- Social care workers (personal care workers), practicing, head count
- Practising dentists, per 10 000 population
- Practising dentists, head count
- Practising midwives, per 10 000 population
- Practising midwives, head count
- Practising nurses, per 10 000 population
- Total practising nurses, head count
- Practising pharmacists, per 10 000 population
- Practising pharmacists, head count
- Practising physicians, per 10 000 population
- Practising physicians, head count
- Practising physiotherapists, per 10 000 population
- Practising physiotherapists, head count
- Social care workers (personal care workers), professionally active per 10 000 population
- Social care workers (personal care workers), professionally active, head count
- Professionally active dentists, per 10 000 population
- Professionally active dentists, head count
- Professionally active midwives, per 10 000 population
- Professionally active midwives, head count
- Professionally active nurses, per 10 000 population
- Total professionally active nurses, head count
- Professionally active pharmacists, per 10 000 population
- Professionally active pharmacists, head count
- Professionally active physicians, per 10 000 population
- Professionally active physicians, head count
- Professional nurses and midwives employed by hospital in FTE, per 10 000 population
- Professional nurses and midwives employed by hospital in FTE, total number
- Professional nurses, licensed to practice, per 10 000 population
- Professional nurses, licensed to practice, head count
- Professional nurses, practising, per 10 000 population
- Professional nurses, practising, head count
- Professional nurses, professionally active, per 10 000 population
- Professional nurses, professionally active, head count
- Professional nursing graduates, per 10 000 population
- Professional nursing graduates, head count
- Psychiatrists, per 10 000 population
- Psychiatrists, head count
- Specialist medical practitioners, per 10 000 population
- Specialist medical practitioners, head count
- Surgical group of specialists, per 10 000 population
- Surgical group of specialists, head count
- Hospital employment in FTE, per 10 000 population
- Total hospital employment in FTE, total number
- Hospital employment, per 10 000 population
- Total hospital employment, head count
- Deaths(#), Accidental drowning and submersion
- CDR(0 year), Accidental drowning and submersion, per 100 000
- SDR(0-14), Accidental drowning and submersion, per 100 000
- SDR(0-64), Accidental drowning and submersion, per 100 000
- SDR(1-19), Accidental drowning and submersion, per 100 000
- CDR(1-4), Accidental drowning and submersion, per 100 000
- SDR(15-24), Accidental drowning and submersion, per 100 000
- SDR(15-29), Accidental drowning and submersion, per 100 000
- SDR(25-64), Accidental drowning and submersion, per 100 000
- SDR(30-44), Accidental drowning and submersion, per 100 000
- SDR(45-59), Accidental drowning and submersion, per 100 000
- SDR(5-14), Accidental drowning and submersion, per 100 000
- SDR(60-74), Accidental drowning and submersion, per 100 000
- SDR(65+), Accidental drowning and submersion, per 100 000
- SDR(75+), Accidental drowning and submersion, per 100 000
- SDR, Accidental drowning and submersion, per 100 000
- Deaths(#), Accidental falls
- CDR(0 year), Accidental falls, per 100 000
- SDR(0-14), Accidental falls, per 100 000
- SDR(0-64), Accidental falls, per 100 000
- SDR(1-19), Accidental falls, per 100 000
- CDR(1-4), Accidental falls, per 100 000
- SDR(15-24), Accidental falls, per 100 000
- SDR(15-29), Accidental falls, per 100 000
- SDR(25-64), Accidental falls, per 100 000
- SDR(30-44), Accidental falls, per 100 000
- SDR(45-59), Accidental falls, per 100 000
- SDR(5-14), Accidental falls, per 100 000
- SDR(60-74), Accidental falls, per 100 000
- SDR(65+), Accidental falls, per 100 000
- SDR(75+), Accidental falls, per 100 000
- SDR, Accidental falls, per 100 000
- Deaths(#), Accidental poisoning
- Deaths(#), Accidental poisoning by alcohol
- SDR(0-14), Accidental poisoning by alcohol, per 100 000
- SDR(0-64), Accidental poisoning by alcohol, per 100 000
- SDR(15-29), Accidental poisoning by alcohol, per 100 000
- SDR(25-64), Accidental poisoning by alcohol, per 100 000
- SDR(30-44), Accidental poisoning by alcohol, per 100 000
- SDR(45-59), Accidental poisoning by alcohol, per 100 000
- SDR(60-74), Accidental poisoning by alcohol, per 100 000
- SDR(65+), Accidental poisoning by alcohol, per 100 000
- SDR(75+), Accidental poisoning by alcohol, per 100 000
- SDR, Accidental poisoning by alcohol, per 100 000
- CDR(0 year), Accidental poisoning, per 100 000
- SDR(0-14), Accidental poisoning, per 100 000
- SDR(0-64), Accidental poisoning, per 100 000
- SDR(1-19), Accidental poisoning, per 100 000
- CDR(1-4), Accidental poisoning, per 100 000
- SDR(15-24), Accidental poisoning, per 100 000
- SDR(15-29), Accidental poisoning, per 100 000
- SDR(25-64), Accidental poisoning, per 100 000
- SDR(30-44), Accidental poisoning, per 100 000
- SDR(45-59), Accidental poisoning, per 100 000
- SDR(5-14), Accidental poisoning, per 100 000
- SDR(60-74), Accidental poisoning, per 100 000
- SDR(65+), Accidental poisoning, per 100 000
- SDR(75+), Accidental poisoning, per 100 000
- SDR, Accidental poisoning, per 100 000
- Deaths(#), Accidents
- CDR(0 year), Accidents, per 100 000
- SDR(0-14), Accidents, per 100 000
- SDR(0-64), Accidents, per 100 000
- SDR(1-19), Accidents, per 100 000
- CDR(1-4), Accidents, per 100 000
- SDR(15-24), Accidents, per 100 000
- SDR(15-29), Accidents, per 100 000
- SDR(25-64), Accidents, per 100 000
- SDR(30-44), Accidents, per 100 000
- SDR(45-59), Accidents, per 100 000
- SDR(5-14), Accidents, per 100 000
- SDR(60-74), Accidents, per 100 000
- SDR(65+), Accidents, per 100 000
- SDR(75+), Accidents, per 100 000
- SDR, Accidents, per 100 000
- Deaths(#), AIDS/HIV (as recorded by routine mortality statistics system)
- SDR(0-14), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
- SDR(0-64), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
- SDR(15-29), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
- SDR(25-64), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
- SDR(30-44), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
- SDR(45-59), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
- SDR(60-74), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
- SDR(65+), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
- SDR(75+), AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
- SDR, AIDS/HIV (as recorded by routine mortality statistics system), per 100 000
- Deaths(#), Alcohol abuse (including alcoholic psychosis)
- SDR(0-14), Alcohol abuse (including alcoholic psychosis), per 100 000
- SDR(0-64), Alcohol abuse (including alcoholic psychosis), per 100 000
- SDR(15-29), Alcohol abuse (including alcoholic psychosis), per 100 000
- SDR(25-64), Alcohol abuse (including alcoholic psychosis), per 100 000
- SDR(30-44), Alcohol abuse (including alcoholic psychosis), per 100 000
- SDR(45-59), Alcohol abuse (including alcoholic psychosis), per 100 000
- SDR(60-74), Alcohol abuse (including alcoholic psychosis), per 100 000
- SDR(65+), Alcohol abuse (including alcoholic psychosis), per 100 000
- SDR(75+), Alcohol abuse (including alcoholic psychosis), per 100 000
- SDR, Alcohol abuse (including alcoholic psychosis), per 100 000
- Deaths(#), All causes
- CDR(0 year), All causes, per 100 000
- SDR(0-14), All causes, per 100 000
- SDR(0-64), All causes, per 100 000
- SDR(1-19), All causes, per 100 000
- CDR(1-4), All causes, per 100 000
- SDR(15-24), All causes, per 100 000
- SDR(15-29), All causes, per 100 000
- SDR(25-64), All causes, per 100 000
- SDR(30-44), All causes, per 100 000
- SDR(45-59), All causes, per 100 000
- SDR(5-14), All causes, per 100 000
- SDR(60-74), All causes, per 100 000
- SDR(65+), All causes, per 100 000
- SDR(75+), All causes, per 100 000
- SDR, All causes, per 100 000
- Deaths(#), Alzheimer's disease and other degenerative diseases of nervous system
- SDR(0-14), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
- SDR(0-64), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
- SDR(15-29), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
- SDR(25-64), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
- SDR(30-44), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
- SDR(45-59), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
- SDR(60-74), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
- SDR(65+), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
- SDR(75+), Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
- SDR, Alzheimer's disease and other degenerative diseases of nervous system, per 100 000
- Deaths(#), Asthma
- SDR(0-14), Asthma, per 100 000
- SDR(0-64), Asthma, per 100 000
- SDR(15-29), Asthma, per 100 000
- SDR(25-64), Asthma, per 100 000
- SDR(30-44), Asthma, per 100 000
- SDR(45-59), Asthma, per 100 000
- SDR(60-74), Asthma, per 100 000
- SDR(65+), Asthma, per 100 000
- SDR(75+), Asthma, per 100 000
- SDR, Asthma, per 100 000
- Deaths(#), Cerebrovascular diseases
- SDR(0-14), Cerebrovascular diseases, per 100 000
- SDR(0-64), Cerebrovascular diseases, per 100 000
- SDR(15-29), Cerebrovascular diseases, per 100 000
- SDR(25-64), Cerebrovascular diseases, per 100 000
- SDR(30-44), Cerebrovascular diseases, per 100 000
- SDR(45-59), Cerebrovascular diseases, per 100 000
- SDR(60-74), Cerebrovascular diseases, per 100 000
- SDR(65+), Cerebrovascular diseases, per 100 000
- SDR(75+), Cerebrovascular diseases, per 100 000
- SDR, Cerebrovascular diseases, per 100 000
- Deaths(#), Certain conditions originating in the perinatal period
- CDR(0 year), Certain conditions originating in the perinatal period, per 100 000
- Deaths(#), Chronic liver disease and cirrhosis
- SDR(0-14), Chronic liver disease and cirrhosis, per 100 000
- SDR(0-64), Chronic liver disease and cirrhosis, per 100 000
- SDR(15-29), Chronic liver disease and cirrhosis, per 100 000
- SDR(25-64), Chronic liver disease and cirrhosis, per 100 000
- SDR(30-44), Chronic liver disease and cirrhosis, per 100 000
- SDR(45-59), Chronic liver disease and cirrhosis, per 100 000
- SDR(60-74), Chronic liver disease and cirrhosis, per 100 000
- SDR(65+), Chronic liver disease and cirrhosis, per 100 000
- SDR(75+), Chronic liver disease and cirrhosis, per 100 000
- SDR, Chronic liver disease and cirrhosis, per 100 000
- Deaths(#), Chronic lower respiratory diseases
- SDR(0-14), Chronic lower respiratory diseases, per 100 000
- SDR(0-64), Chronic lower respiratory diseases, per 100 000
- SDR(15-29), Chronic lower respiratory diseases, per 100 000
- SDR(25-64), Chronic lower respiratory diseases, per 100 000
- SDR(30-44), Chronic lower respiratory diseases, per 100 000
- SDR(45-59), Chronic lower respiratory diseases, per 100 000
- SDR(60-74), Chronic lower respiratory diseases, per 100 000
- SDR(65+), Chronic lower respiratory diseases, per 100 000
- SDR(75+), Chronic lower respiratory diseases, per 100 000
- SDR, Chronic lower respiratory diseases, per 100 000
- SDR, females, Complications of pregnancy, childbirth and puerperium, per 100 000
- Deaths(#), females, Complications of pregnancy, childbirth and puerperium
- Deaths(#), Congenital malformations and chromosomal abnormalities
- CDR(0 year), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(0-14), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(0-64), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(1-19), Congenital malformations and chromosomal abnormalities, per 100 000
- CDR(1-4), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(15-24), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(15-29), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(25-64), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(30-44), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(45-59), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(5-14), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(60-74), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(65+), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR(75+), Congenital malformations and chromosomal abnormalities, per 100 000
- SDR, Congenital malformations and chromosomal abnormalities, per 100 000
- Deaths(#), Diabetes mellitus
- SDR(0-14), Diabetes mellitus, per 100 000
- SDR(0-64), Diabetes mellitus, per 100 000
- SDR(15-29), Diabetes mellitus, per 100 000
- SDR(25-64), Diabetes mellitus, per 100 000
- SDR(30-44), Diabetes mellitus, per 100 000
- SDR(45-59), Diabetes mellitus, per 100 000
- SDR(60-74), Diabetes mellitus, per 100 000
- SDR(65+), Diabetes mellitus, per 100 000
- SDR(75+), Diabetes mellitus, per 100 000
- SDR, Diabetes mellitus, per 100 000
- Deaths(#), Diseases of genitourinary system
- SDR(0-14), Diseases of genitourinary system, per 100 000
- SDR(0-64), Diseases of genitourinary system, per 100 000
- SDR(15-29), Diseases of genitourinary system, per 100 000
- SDR(25-64), Diseases of genitourinary system, per 100 000
- SDR(30-44), Diseases of genitourinary system, per 100 000
- SDR(45-59), Diseases of genitourinary system, per 100 000
- SDR(60-74), Diseases of genitourinary system, per 100 000
- SDR(65+), Diseases of genitourinary system, per 100 000
- SDR(75+), Diseases of genitourinary system, per 100 000
- SDR, Diseases of genitourinary system, per 100 000
- Deaths(#), Diseases of musculoskeletal system and connective tissue
- SDR(0-14), Diseases of musculoskeletal system and connective tissue, per 100 000
- SDR(0-64), Diseases of musculoskeletal system and connective tissue, per 100 000
- SDR(15-29), Diseases of musculoskeletal system and connective tissue, per 100 000
- SDR(25-64), Diseases of musculoskeletal system and connective tissue, per 100 000
- SDR(30-44), Diseases of musculoskeletal system and connective tissue, per 100 000
- SDR(45-59), Diseases of musculoskeletal system and connective tissue, per 100 000
- SDR(60-74), Diseases of musculoskeletal system and connective tissue, per 100 000
- SDR(65+), Diseases of musculoskeletal system and connective tissue, per 100 000
- SDR(75+), Diseases of musculoskeletal system and connective tissue, per 100 000
- SDR, Diseases of musculoskeletal system and connective tissue, per 100 000
- Deaths(#), Diseases of nervous system and sense organs
- SDR(0-14), Diseases of nervous system and sense organs, per 100 000
- SDR(0-64), Diseases of nervous system and sense organs, per 100 000
- SDR(15-29), Diseases of nervous system and sense organs, per 100 000
- SDR(25-64), Diseases of nervous system and sense organs, per 100 000
- SDR(30-44), Diseases of nervous system and sense organs, per 100 000
- SDR(45-59), Diseases of nervous system and sense organs, per 100 000
- SDR(60-74), Diseases of nervous system and sense organs, per 100 000
- SDR(65+), Diseases of nervous system and sense organs, per 100 000
- SDR(75+), Diseases of nervous system and sense organs, per 100 000
- SDR, Diseases of nervous system and sense organs, per 100 000
- Deaths(#), Diseases of skin and subcutaneous tissue
- SDR(0-14), Diseases of skin and subcutaneous tissue, per 100 000
- SDR(0-64), Diseases of skin and subcutaneous tissue, per 100 000
- SDR(15-29), Diseases of skin and subcutaneous tissue, per 100 000
- SDR(25-64), Diseases of skin and subcutaneous tissue, per 100 000
- SDR(30-44), Diseases of skin and subcutaneous tissue, per 100 000
- SDR(45-59), Diseases of skin and subcutaneous tissue, per 100 000
- SDR(60-74), Diseases of skin and subcutaneous tissue, per 100 000
- SDR(65+), Diseases of skin and subcutaneous tissue, per 100 000
- SDR(75+), Diseases of skin and subcutaneous tissue, per 100 000
- SDR, Diseases of skin and subcutaneous tissue, per 100 000
- Deaths(#), Diseases of the blood, blood forming organs and certain immunity disorders
- CDR(0 year), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(0-14), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(0-64), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(1-19), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- CDR(1-4), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(15-24), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(15-29), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(25-64), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(30-44), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(45-59), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(5-14), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(60-74), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(65+), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR(75+), Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- SDR, Diseases of the blood, blood forming organs and certain immunity disorders, per 100 000
- Deaths(#), Diseases of the circulatory system
- CDR(0 year), Diseases of the circulatory system, per 100 000
- SDR(0-14), Diseases of the circulatory system, per 100 000
- SDR(0-64), Diseases of the circulatory system, per 100 000
- SDR(1-19), Diseases of the circulatory system, per 100 000
- CDR(1-4), Diseases of the circulatory system, per 100 000
- SDR(15-24), Diseases of the circulatory system, per 100 000
- SDR(15-29), Diseases of the circulatory system, per 100 000
- SDR(25-64), Diseases of the circulatory system, per 100 000
- SDR(30-44), Diseases of the circulatory system, per 100 000
- SDR(45-59), Diseases of the circulatory system, per 100 000
- SDR(5-14), Diseases of the circulatory system, per 100 000
- SDR(60-74), Diseases of the circulatory system, per 100 000
- SDR(65+), Diseases of the circulatory system, per 100 000
- SDR(75+), Diseases of the circulatory system, per 100 000
- SDR, Diseases of the circulatory system, per 100 000
- Deaths(#), Diseases of the digestive system
- CDR(0 year), Diseases of the digestive system, per 100 000
- SDR(0-14), Diseases of the digestive system, per 100 000
- SDR(0-64), Diseases of the digestive system, per 100 000
- SDR(1-19), Diseases of the digestive system, per 100 000
- CDR(1-4), Diseases of the digestive system, per 100 000
- SDR(15-24), Diseases of the digestive system, per 100 000
- SDR(15-29), Diseases of the digestive system, per 100 000
- SDR(25-64), Diseases of the digestive system, per 100 000
- SDR(30-44), Diseases of the digestive system, per 100 000
- SDR(45-59), Diseases of the digestive system, per 100 000
- SDR(5-14), Diseases of the digestive system, per 100 000
- SDR(60-74), Diseases of the digestive system, per 100 000
- SDR(65+), Diseases of the digestive system, per 100 000
- SDR(75+), Diseases of the digestive system, per 100 000
- SDR, Diseases of the digestive system, per 100 000
- Deaths(#), Diseases of the respiratory system
- CDR(0 year), Diseases of the respiratory system, per 100 000
- SDR(0-14), Diseases of the respiratory system, per 100 000
- SDR(0-64), Diseases of the respiratory system, per 100 000
- SDR(1-19), Diseases of the respiratory system, per 100 000
- CDR(1-4), Diseases of the respiratory system, per 100 000
- SDR(15-24), Diseases of the respiratory system, per 100 000
- SDR(15-29), Diseases of the respiratory system, per 100 000
- SDR(25-64), Diseases of the respiratory system, per 100 000
- SDR(30-44), Diseases of the respiratory system, per 100 000
- SDR(45-59), Diseases of the respiratory system, per 100 000
- SDR(5-14), Diseases of the respiratory system, per 100 000
- SDR(60-74), Diseases of the respiratory system, per 100 000
- SDR(65+), Diseases of the respiratory system, per 100 000
- SDR(75+), Diseases of the respiratory system, per 100 000
- SDR, Diseases of the respiratory system, per 100 000
- Deaths(#), Drug dependence and toxicomania
- SDR(0-14), Drug dependence and toxicomania, per 100 000
- SDR(0-64), Drug dependence and toxicomania, per 100 000
- SDR(15-29), Drug dependence and toxicomania, per 100 000
- SDR(25-64), Drug dependence and toxicomania, per 100 000
- SDR(30-44), Drug dependence and toxicomania, per 100 000
- SDR(45-59), Drug dependence and toxicomania, per 100 000
- SDR(60-74), Drug dependence and toxicomania, per 100 000
- SDR(65+), Drug dependence and toxicomania, per 100 000
- SDR(75+), Drug dependence and toxicomania, per 100 000
- SDR, Drug dependence and toxicomania, per 100 000
- Deaths(#), Endocrine, nutritional and metabolic diseases
- CDR(0 year), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(0-14), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(0-64), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(1-19), Endocrine, nutritional and metabolic diseases, per 100 000
- CDR(1-4), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(15-24), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(15-29), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(25-64), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(30-44), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(45-59), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(5-14), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(60-74), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(65+), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR(75+), Endocrine, nutritional and metabolic diseases, per 100 000
- SDR, Endocrine, nutritional and metabolic diseases, per 100 000
- Deaths(#), Events of undetermined intent
- SDR(0-14), Events of undetermined intent, per 100 000
- SDR(0-64), Events of undetermined intent, per 100 000
- SDR(15-29), Events of undetermined intent, per 100 000
- SDR(25-64), Events of undetermined intent, per 100 000
- SDR(30-44), Events of undetermined intent, per 100 000
- SDR(45-59), Events of undetermined intent, per 100 000
- SDR(60-74), Events of undetermined intent, per 100 000
- SDR(65+), Events of undetermined intent, per 100 000
- SDR(75+), Events of undetermined intent, per 100 000
- SDR, Events of undetermined intent, per 100 000
- Deaths(#), Exposure to smoke, fire and flames
- CDR(0 year), Exposure to smoke, fire and flames, per 100 000
- SDR(0-14), Exposure to smoke, fire and flames, per 100 000
- SDR(0-64), Exposure to smoke, fire and flames, per 100 000
- SDR(1-19), Exposure to smoke, fire and flames, per 100 000
- CDR(1-4), Exposure to smoke, fire and flames, per 100 000
- SDR(15-24), Exposure to smoke, fire and flames, per 100 000
- SDR(15-29), Exposure to smoke, fire and flames, per 100 000
- SDR(25-64), Exposure to smoke, fire and flames, per 100 000
- SDR(30-44), Exposure to smoke, fire and flames, per 100 000
- SDR(45-59), Exposure to smoke, fire and flames, per 100 000
- SDR(5-14), Exposure to smoke, fire and flames, per 100 000
- SDR(60-74), Exposure to smoke, fire and flames, per 100 000
- SDR(65+), Exposure to smoke, fire and flames, per 100 000
- SDR(75+), Exposure to smoke, fire and flames, per 100 000
- SDR, Exposure to smoke, fire and flames, per 100 000
- Deaths(#), External causes of injury and poisoning
- CDR(0 year), External causes of injury and poisoning, per 100 000
- SDR(0-14), External causes of injury and poisoning, per 100 000
- SDR(0-64), External causes of injury and poisoning, per 100 000
- SDR(1-19), External causes of injury and poisoning, per 100 000
- CDR(1-4), External causes of injury and poisoning, per 100 000
- SDR(15-24), External causes of injury and poisoning, per 100 000
- SDR(15-29), External causes of injury and poisoning, per 100 000
- SDR(25-64), External causes of injury and poisoning, per 100 000
- SDR(30-44), External causes of injury and poisoning, per 100 000
- SDR(45-59), External causes of injury and poisoning, per 100 000
- SDR(5-14), External causes of injury and poisoning, per 100 000
- SDR(60-74), External causes of injury and poisoning, per 100 000
- SDR(65+), External causes of injury and poisoning, per 100 000
- SDR(75+), External causes of injury and poisoning, per 100 000
- SDR, External causes of injury and poisoning, per 100 000
- Deaths(#), Homicide and assault
- SDR(0-14), Homicide and assault, per 100 000
- SDR(0-64), Homicide and assault, per 100 000
- SDR(15-29), Homicide and assault, per 100 000
- SDR(25-64), Homicide and assault, per 100 000
- SDR(30-44), Homicide and assault, per 100 000
- SDR(45-59), Homicide and assault, per 100 000
- SDR(60-74), Homicide and assault, per 100 000
- SDR(65+), Homicide and assault, per 100 000
- SDR(75+), Homicide and assault, per 100 000
- SDR, Homicide and assault, per 100 000
- Deaths(#), Infectious and parasitic diseases
- CDR(0 year), Infectious and parasitic diseases, per 100 000
- SDR(0-14), Infectious and parasitic diseases, per 100 000
- SDR(0-64), Infectious and parasitic diseases, per 100 000
- SDR(1-19), Infectious and parasitic diseases, per 100 000
- CDR(1-4), Infectious and parasitic diseases, per 100 000
- SDR(15-24), Infectious and parasitic diseases, per 100 000
- SDR(15-29), Infectious and parasitic diseases, per 100 000
- SDR(25-64), Infectious and parasitic diseases, per 100 000
- SDR(30-44), Infectious and parasitic diseases, per 100 000
- SDR(45-59), Infectious and parasitic diseases, per 100 000
- SDR(5-14), Infectious and parasitic diseases, per 100 000
- SDR(60-74), Infectious and parasitic diseases, per 100 000
- SDR(65+), Infectious and parasitic diseases, per 100 000
- SDR(75+), Infectious and parasitic diseases, per 100 000
- SDR, Infectious and parasitic diseases, per 100 000
- Deaths(#), Influenza
- SDR(0-14), Influenza, per 100 000
- SDR(0-64), Influenza, per 100 000
- SDR(15-29), Influenza, per 100 000
- SDR(25-64), Influenza, per 100 000
- SDR(30-44), Influenza, per 100 000
- SDR(45-59), Influenza, per 100 000
- SDR(60-74), Influenza, per 100 000
- SDR(65+), Influenza, per 100 000
- SDR(75+), Influenza, per 100 000
- SDR, Influenza, per 100 000
- Deaths(#), Intestinal infectious diseases
- SDR(0-14), Intestinal infectious diseases, per 100 000
- SDR(0-64), Intestinal infectious diseases, per 100 000
- SDR(15-29), Intestinal infectious diseases, per 100 000
- SDR(25-64), Intestinal infectious diseases, per 100 000
- SDR(30-44), Intestinal infectious diseases, per 100 000
- SDR(45-59), Intestinal infectious diseases, per 100 000
- SDR(60-74), Intestinal infectious diseases, per 100 000
- SDR(65+), Intestinal infectious diseases, per 100 000
- SDR(75+), Intestinal infectious diseases, per 100 000
- SDR, Intestinal infectious diseases, per 100 000
- Deaths(#), Ischaemic heart disease
- SDR(0-14), Ischaemic heart disease, per 100 000
- SDR(0-64), Ischaemic heart disease, per 100 000
- SDR(15-29), Ischaemic heart disease, per 100 000
- SDR(25-64), Ischaemic heart disease, per 100 000
- SDR(30-44), Ischaemic heart disease, per 100 000
- SDR(45-59), Ischaemic heart disease, per 100 000
- SDR(60-74), Ischaemic heart disease, per 100 000
- SDR(65+), Ischaemic heart disease, per 100 000
- SDR(75+), Ischaemic heart disease, per 100 000
- SDR, Ischaemic heart disease, per 100 000
- Deaths(#), Malignant melanoma of skin
- SDR(0-14), Malignant melanoma of skin, per 100 000
- SDR(0-64), Malignant melanoma of skin, per 100 000
- SDR(15-29), Malignant melanoma of skin, per 100 000
- SDR(25-64), Malignant melanoma of skin, per 100 000
- SDR(30-44), Malignant melanoma of skin, per 100 000
- SDR(45-59), Malignant melanoma of skin, per 100 000
- SDR(60-74), Malignant melanoma of skin, per 100 000
- SDR(65+), Malignant melanoma of skin, per 100 000
- SDR(75+), Malignant melanoma of skin, per 100 000
- SDR, Malignant melanoma of skin, per 100 000
- Deaths(#), Malignant neoplasm of bladder
- SDR(0-14), Malignant neoplasm of bladder, per 100 000
- SDR(0-64), Malignant neoplasm of bladder, per 100 000
- SDR(15-29), Malignant neoplasm of bladder, per 100 000
- SDR(25-64), Malignant neoplasm of bladder, per 100 000
- SDR(30-44), Malignant neoplasm of bladder, per 100 000
- SDR(45-59), Malignant neoplasm of bladder, per 100 000
- SDR(60-74), Malignant neoplasm of bladder, per 100 000
- SDR(65+), Malignant neoplasm of bladder, per 100 000
- SDR(75+), Malignant neoplasm of bladder, per 100 000
- SDR, Malignant neoplasm of bladder, per 100 000
- Deaths(#), Malignant neoplasm of breast
- SDR(0-14), Malignant neoplasm of breast, per 100 000
- SDR(0-64), Malignant neoplasm of breast, per 100 000
- SDR(15-29), Malignant neoplasm of breast, per 100 000
- SDR(25-64), Malignant neoplasm of breast, per 100 000
- SDR(30-44), Malignant neoplasm of breast, per 100 000
- SDR(45-59), Malignant neoplasm of breast, per 100 000
- SDR(60-74), Malignant neoplasm of breast, per 100 000
- SDR(65+), Malignant neoplasm of breast, per 100 000
- SDR(75+), Malignant neoplasm of breast, per 100 000
- SDR, Malignant neoplasm of breast, per 100 000
- Deaths(#), females, Malignant neoplasm of cervix uteri
- SDR(0-14), females, Malignant neoplasm of cervix uteri, per 100 000
- SDR(0-64), females, Malignant neoplasm of cervix uteri, per 100 000
- SDR(15-29), females, Malignant neoplasm of cervix uteri, per 100 000
- SDR(25-64), females, Malignant neoplasm of cervix uteri, per 100 000
- SDR(30-44), females, Malignant neoplasm of cervix uteri, per 100 000
- SDR(45-59), females, Malignant neoplasm of cervix uteri, per 100 000
- SDR(60-74), females, Malignant neoplasm of cervix uteri, per 100 000
- SDR(65+), females, Malignant neoplasm of cervix uteri, per 100 000
- SDR(75+), females, Malignant neoplasm of cervix uteri, per 100 000
- SDR, females, Malignant neoplasm of cervix uteri, per 100 000
- Deaths(#), Malignant neoplasm of colon, rectum and anus
- SDR(0-14), Malignant neoplasm of colon, rectum and anus, per 100 000
- SDR(0-64), Malignant neoplasm of colon, rectum and anus, per 100 000
- SDR(15-29), Malignant neoplasm of colon, rectum and anus, per 100 000
- SDR(25-64), Malignant neoplasm of colon, rectum and anus, per 100 000
- SDR(30-44), Malignant neoplasm of colon, rectum and anus, per 100 000
- SDR(45-59), Malignant neoplasm of colon, rectum and anus, per 100 000
- SDR(60-74), Malignant neoplasm of colon, rectum and anus, per 100 000
- SDR(65+), Malignant neoplasm of colon, rectum and anus, per 100 000
- SDR(75+), Malignant neoplasm of colon, rectum and anus, per 100 000
- SDR, Malignant neoplasm of colon, rectum and anus, per 100 000
- Deaths(#), Malignant neoplasm of esophagus
- SDR(0-14), Malignant neoplasm of esophagus, per 100 000
- SDR(0-64), Malignant neoplasm of esophagus, per 100 000
- SDR(15-29), Malignant neoplasm of esophagus, per 100 000
- SDR(25-64), Malignant neoplasm of esophagus, per 100 000
- SDR(30-44), Malignant neoplasm of esophagus, per 100 000
- SDR(45-59), Malignant neoplasm of esophagus, per 100 000
- SDR(60-74), Malignant neoplasm of esophagus, per 100 000
- SDR(65+), Malignant neoplasm of esophagus, per 100 000
- SDR(75+), Malignant neoplasm of esophagus, per 100 000
- SDR, Malignant neoplasm of esophagus, per 100 000
- Deaths(#), Malignant neoplasm of larynx, trachea, bronchus and lung
- SDR(0-14), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
- SDR(0-64), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
- SDR(15-29), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
- SDR(25-64), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
- SDR(30-44), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
- SDR(45-59), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
- SDR(60-74), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
- SDR(65+), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
- SDR(75+), Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
- SDR, Malignant neoplasm of larynx, trachea, bronchus and lung, per 100 000
- Deaths(#), Malignant neoplasm of lip/oral cavity/pharynx
- SDR(0-14), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
- SDR(0-64), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
- SDR(15-29), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
- SDR(25-64), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
- SDR(30-44), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
- SDR(45-59), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
- SDR(60-74), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
- SDR(65+), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
- SDR(75+), Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
- SDR, Malignant neoplasm of lip/oral cavity/pharynx, per 100 000
- Deaths(#), Malignant neoplasm of liver and intrahepatic bile ducts
- SDR(0-14), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
- SDR(0-64), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
- SDR(15-29), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
- SDR(25-64), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
- SDR(30-44), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
- SDR(45-59), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
- SDR(60-74), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
- SDR(65+), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
- SDR(75+), Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
- SDR, Malignant neoplasm of liver and intrahepatic bile ducts, per 100 000
- Deaths(#), Malignant neoplasm of lymphoid and haematopoietic tissue
- CDR(0 year), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(0-14), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(0-64), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(1-19), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- CDR(1-4), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(15-24), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(15-29), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(25-64), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(30-44), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(45-59), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(5-14), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(60-74), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(65+), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR(75+), Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- SDR, Malignant neoplasm of lymphoid and haematopoietic tissue, per 100 000
- Deaths(#), females, Malignant neoplasm of other parts of uterus
- SDR(0-14), females, Malignant neoplasm of other parts of uterus, per 100 000
- SDR(0-64), females, Malignant neoplasm of other parts of uterus, per 100 000
- SDR(15-29), females, Malignant neoplasm of other parts of uterus, per 100 000
- SDR(25-64), females, Malignant neoplasm of other parts of uterus, per 100 000
- SDR(30-44), females, Malignant neoplasm of other parts of uterus, per 100 000
- SDR(45-59), females, Malignant neoplasm of other parts of uterus, per 100 000
- SDR(60-74), females, Malignant neoplasm of other parts of uterus, per 100 000
- SDR(65+), females, Malignant neoplasm of other parts of uterus, per 100 000
- SDR(75+), females, Malignant neoplasm of other parts of uterus, per 100 000
- SDR, females, Malignant neoplasm of other parts of uterus, per 100 000
- Deaths(#), females, Malignant neoplasm of ovary
- SDR(0-14), females, Malignant neoplasm of ovary, per 100 000
- SDR(0-64), females, Malignant neoplasm of ovary, per 100 000
- SDR(15-29), females, Malignant neoplasm of ovary, per 100 000
- SDR(25-64), females, Malignant neoplasm of ovary, per 100 000
- SDR(30-44), females, Malignant neoplasm of ovary, per 100 000
- SDR(45-59), females, Malignant neoplasm of ovary, per 100 000
- SDR(60-74), females, Malignant neoplasm of ovary, per 100 000
- SDR(65+), females, Malignant neoplasm of ovary, per 100 000
- SDR(75+), females, Malignant neoplasm of ovary, per 100 000
- SDR, females, Malignant neoplasm of ovary, per 100 000
- Deaths(#), males, Malignant neoplasm of prostate
- SDR(0-14), males, Malignant neoplasm of prostate, per 100 000
- SDR(0-64), males, Malignant neoplasm of prostate, per 100 000
- SDR(15-29), males, Malignant neoplasm of prostate, per 100 000
- SDR(25-64), males, Malignant neoplasm of prostate, per 100 000
- SDR(30-44), males, Malignant neoplasm of prostate, per 100 000
- SDR(45-59), males, Malignant neoplasm of prostate, per 100 000
- SDR(60-74), males, Malignant neoplasm of prostate, per 100 000
- SDR(65+), males, Malignant neoplasm of prostate, per 100 000
- SDR(75+), males, Malignant neoplasm of prostate, per 100 000
- SDR, males, Malignant neoplasm of prostate, per 100 000
- Deaths(#), Malignant neoplasm of pancreas
- SDR(0-14), Malignant neoplasm of pancreas, per 100 000
- SDR(0-64), Malignant neoplasm of pancreas, per 100 000
- SDR(15-29), Malignant neoplasm of pancreas, per 100 000
- SDR(25-64), Malignant neoplasm of pancreas, per 100 000
- SDR(30-44), Malignant neoplasm of pancreas, per 100 000
- SDR(45-59), Malignant neoplasm of pancreas, per 100 000
- SDR(60-74), Malignant neoplasm of pancreas, per 100 000
- SDR(65+), Malignant neoplasm of pancreas, per 100 000
- SDR(75+), Malignant neoplasm of pancreas, per 100 000
- SDR, Malignant neoplasm of pancreas, per 100 000
- Deaths(#), Malignant neoplasm of stomach
- SDR(0-14), Malignant neoplasm of stomach, per 100 000
- SDR(0-64), Malignant neoplasm of stomach, per 100 000
- SDR(15-29), Malignant neoplasm of stomach, per 100 000
- SDR(25-64), Malignant neoplasm of stomach, per 100 000
- SDR(30-44), Malignant neoplasm of stomach, per 100 000
- SDR(45-59), Malignant neoplasm of stomach, per 100 000
- SDR(60-74), Malignant neoplasm of stomach, per 100 000
- SDR(65+), Malignant neoplasm of stomach, per 100 000
- SDR(75+), Malignant neoplasm of stomach, per 100 000
- SDR, Malignant neoplasm of stomach, per 100 000
- Deaths(#), Malignant neoplasm of trachea, bronchus and lung
- SDR(0-14), Malignant neoplasm of trachea, bronchus and lung, per 100 000
- SDR(0-64), Malignant neoplasm of trachea, bronchus and lung, per 100 000
- SDR(15-29), Malignant neoplasm of trachea, bronchus and lung, per 100 000
- SDR(25-64), Malignant neoplasm of trachea, bronchus and lung, per 100 000
- SDR(30-44), Malignant neoplasm of trachea, bronchus and lung, per 100 000
- SDR(45-59), Malignant neoplasm of trachea, bronchus and lung, per 100 000
- SDR(60-74), Malignant neoplasm of trachea, bronchus and lung, per 100 000
- SDR(65+), Malignant neoplasm of trachea, bronchus and lung, per 100 000
- SDR(75+), Malignant neoplasm of trachea, bronchus and lung, per 100 000
- SDR, Malignant neoplasm of trachea, bronchus and lung, per 100 000
- Deaths(#), Malignant neoplasms
- CDR(0 year), Malignant neoplasms, per 100 000
- SDR(0-14), Malignant neoplasms, per 100 000
- SDR(0-64), Malignant neoplasms, per 100 000
- SDR(1-19), Malignant neoplasms, per 100 000
- CDR(1-4), Malignant neoplasms, per 100 000
- SDR(15-24), Malignant neoplasms, per 100 000
- SDR(15-29), Malignant neoplasms, per 100 000
- SDR(25-64), Malignant neoplasms, per 100 000
- SDR(30-44), Malignant neoplasms, per 100 000
- SDR(45-59), Malignant neoplasms, per 100 000
- SDR(5-14), Malignant neoplasms, per 100 000
- SDR(60-74), Malignant neoplasms, per 100 000
- SDR(65+), Malignant neoplasms, per 100 000
- SDR(75+), Malignant neoplasms, per 100 000
- SDR, Malignant neoplasms, per 100 000
- Deaths(#), Meningitis
- SDR(0-14), Meningitis, per 100 000
- SDR(0-64), Meningitis, per 100 000
- SDR(15-29), Meningitis, per 100 000
- SDR(25-64), Meningitis, per 100 000
- SDR(30-44), Meningitis, per 100 000
- SDR(45-59), Meningitis, per 100 000
- SDR(60-74), Meningitis, per 100 000
- SDR(65+), Meningitis, per 100 000
- SDR(75+), Meningitis, per 100 000
- SDR, Meningitis, per 100 000
- Deaths(#), Meningococcal infection
- SDR(0-14), Meningococcal infection, per 100 000
- SDR(0-64), Meningococcal infection, per 100 000
- SDR(15-29), Meningococcal infection, per 100 000
- SDR(25-64), Meningococcal infection, per 100 000
- SDR(30-44), Meningococcal infection, per 100 000
- SDR(45-59), Meningococcal infection, per 100 000
- SDR(60-74), Meningococcal infection, per 100 000
- SDR(65+), Meningococcal infection, per 100 000
- SDR(75+), Meningococcal infection, per 100 000
- SDR, Meningococcal infection, per 100 000
- Deaths(#), Mental and behavioural disorders
- SDR(0-14), Mental and behavioural disorders, per 100 000
- SDR(0-64), Mental and behavioural disorders, per 100 000
- SDR(15-29), Mental and behavioural disorders, per 100 000
- SDR(25-64), Mental and behavioural disorders, per 100 000
- SDR(30-44), Mental and behavioural disorders, per 100 000
- SDR(45-59), Mental and behavioural disorders, per 100 000
- SDR(60-74), Mental and behavioural disorders, per 100 000
- SDR(65+), Mental and behavioural disorders, per 100 000
- SDR(75+), Mental and behavioural disorders, per 100 000
- SDR, Mental and behavioural disorders, per 100 000
- Deaths(#), Motor vehicle traffic accidents
- CDR(0 year), Motor vehicle traffic accidents, per 100 000
- SDR(0-14), Motor vehicle traffic accidents, per 100 000
- SDR(0-64), Motor vehicle traffic accidents, per 100 000
- SDR(1-19), Motor vehicle traffic accidents, per 100 000
- CDR(1-4), Motor vehicle traffic accidents, per 100 000
- SDR(15-24), Motor vehicle traffic accidents, per 100 000
- SDR(15-29), Motor vehicle traffic accidents, per 100 000
- SDR(25-64), Motor vehicle traffic accidents, per 100 000
- SDR(30-44), Motor vehicle traffic accidents, per 100 000
- SDR(45-59), Motor vehicle traffic accidents, per 100 000
- SDR(5-14), Motor vehicle traffic accidents, per 100 000
- SDR(60-74), Motor vehicle traffic accidents, per 100 000
- SDR(65+), Motor vehicle traffic accidents, per 100 000
- SDR(75+), Motor vehicle traffic accidents, per 100 000
- SDR, Motor vehicle traffic accidents, per 100 000
- Deaths(#), Neoplasms
- CDR(0 year), Neoplasms, per 100 000
- SDR(0-14), Neoplasms, per 100 000
- SDR(0-64), Neoplasms, per 100 000
- SDR(1-19), Neoplasms, per 100 000
- CDR(1-4), Neoplasms, per 100 000
- SDR(15-24), Neoplasms, per 100 000
- SDR(15-29), Neoplasms, per 100 000
- SDR(25-64), Neoplasms, per 100 000
- SDR(30-44), Neoplasms, per 100 000
- SDR(45-59), Neoplasms, per 100 000
- SDR(5-14), Neoplasms, per 100 000
- SDR(60-74), Neoplasms, per 100 000
- SDR(65+), Neoplasms, per 100 000
- SDR(75+), Neoplasms, per 100 000
- SDR, Neoplasms, per 100 000
- Deaths(#), Other acute respiratory infections
- SDR(0-14), Other acute respiratory infections, per 100 000
- SDR(0-64), Other acute respiratory infections, per 100 000
- SDR(15-29), Other acute respiratory infections, per 100 000
- SDR(25-64), Other acute respiratory infections, per 100 000
- SDR(30-44), Other acute respiratory infections, per 100 000
- SDR(45-59), Other acute respiratory infections, per 100 000
- SDR(60-74), Other acute respiratory infections, per 100 000
- SDR(65+), Other acute respiratory infections, per 100 000
- SDR(75+), Other acute respiratory infections, per 100 000
- SDR, Other acute respiratory infections, per 100 000
- Deaths(#), Pneumonia
- CDR(0 year), Pneumonia, per 100 000
- SDR(0-14), Pneumonia, per 100 000
- SDR(0-64), Pneumonia, per 100 000
- SDR(1-19), Pneumonia, per 100 000
- CDR(1-4), Pneumonia, per 100 000
- SDR(15-24), Pneumonia, per 100 000
- SDR(15-29), Pneumonia, per 100 000
- SDR(25-64), Pneumonia, per 100 000
- SDR(30-44), Pneumonia, per 100 000
- SDR(45-59), Pneumonia, per 100 000
- SDR(5-14), Pneumonia, per 100 000
- SDR(60-74), Pneumonia, per 100 000
- SDR(65+), Pneumonia, per 100 000
- SDR(75+), Pneumonia, per 100 000
- SDR, Pneumonia, per 100 000
- Deaths(#), Psychoactive substance use
- SDR(0-14), Psychoactive substance use, per 100 000
- SDR(0-64), Psychoactive substance use, per 100 000
- SDR(15-29), Psychoactive substance use, per 100 000
- SDR(25-64), Psychoactive substance use, per 100 000
- SDR(30-44), Psychoactive substance use, per 100 000
- SDR(45-59), Psychoactive substance use, per 100 000
- SDR(60-74), Psychoactive substance use, per 100 000
- SDR(65+), Psychoactive substance use, per 100 000
- SDR(75+), Psychoactive substance use, per 100 000
- SDR, Psychoactive substance use, per 100 000
- Deaths(#), Pulmonary heart disease and other heart diseases
- SDR(0-14), Pulmonary heart disease and other heart diseases, per 100 000
- SDR(0-64), Pulmonary heart disease and other heart diseases, per 100 000
- SDR(15-29), Pulmonary heart disease and other heart diseases, per 100 000
- SDR(25-64), Pulmonary heart disease and other heart diseases, per 100 000
- SDR(30-44), Pulmonary heart disease and other heart diseases, per 100 000
- SDR(45-59), Pulmonary heart disease and other heart diseases, per 100 000
- SDR(60-74), Pulmonary heart disease and other heart diseases, per 100 000
- SDR(65+), Pulmonary heart disease and other heart diseases, per 100 000
- SDR(75+), Pulmonary heart disease and other heart diseases, per 100 000
- SDR, Pulmonary heart disease and other heart diseases, per 100 000
- Deaths(#), Sudden and unattended death, cause unknown
- CDR(0 year), Sudden and unattended death, cause unknown, per 100 000
- SDR(0-14), Sudden and unattended death, cause unknown, per 100 000
- SDR(0-64), Sudden and unattended death, cause unknown, per 100 000
- SDR(15-29), Sudden and unattended death, cause unknown, per 100 000
- SDR(25-64), Sudden and unattended death, cause unknown, per 100 000
- SDR(30-44), Sudden and unattended death, cause unknown, per 100 000
- SDR(45-59), Sudden and unattended death, cause unknown, per 100 000
- SDR(60-74), Sudden and unattended death, cause unknown, per 100 000
- SDR(65+), Sudden and unattended death, cause unknown, per 100 000
- SDR(75+), Sudden and unattended death, cause unknown, per 100 000
- SDR, Sudden and unattended death, cause unknown, per 100 000
- Deaths(#), Suicide and intentional self-harm
- SDR(0-14), Suicide and intentional self-harm, per 100 000
- SDR(0-64), Suicide and intentional self-harm, per 100 000
- SDR(15-29), Suicide and intentional self-harm, per 100 000
- SDR(25-64), Suicide and intentional self-harm, per 100 000
- SDR(30-44), Suicide and intentional self-harm, per 100 000
- SDR(45-59), Suicide and intentional self-harm, per 100 000
- SDR(60-74), Suicide and intentional self-harm, per 100 000
- SDR(65+), Suicide and intentional self-harm, per 100 000
- SDR(75+), Suicide and intentional self-harm, per 100 000
- SDR, Suicide and intentional self-harm, per 100 000
- Deaths(#), Symptoms, signs, abnormal findings, ill-defined causes
- SDR(0-14), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
- SDR(0-64), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
- SDR(15-29), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
- SDR(25-64), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
- SDR(30-44), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
- SDR(45-59), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
- SDR(60-74), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
- SDR(65+), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
- SDR(75+), Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
- SDR, Symptoms, signs, abnormal findings, ill-defined causes, per 100 000
- Deaths(#), Transport accidents
- CDR(0 year), Transport accidents, per 100 000
- SDR(0-14), Transport accidents, per 100 000
- SDR(0-64), Transport accidents, per 100 000
- SDR(1-19), Transport accidents, per 100 000
- CDR(1-4), Transport accidents, per 100 000
- SDR(15-24), Transport accidents, per 100 000
- SDR(15-29), Transport accidents, per 100 000
- SDR(25-64), Transport accidents, per 100 000
- SDR(30-44), Transport accidents, per 100 000
- SDR(45-59), Transport accidents, per 100 000
- SDR(5-14), Transport accidents, per 100 000
- SDR(60-74), Transport accidents, per 100 000
- SDR(65+), Transport accidents, per 100 000
- SDR(75+), Transport accidents, per 100 000
- SDR, Transport accidents, per 100 000
- Deaths(#), Tuberculosis
- SDR(0-14), Tuberculosis, per 100 000
- SDR(0-64), Tuberculosis, per 100 000
- SDR(15-29), Tuberculosis, per 100 000
- SDR(25-64), Tuberculosis, per 100 000
- SDR(30-44), Tuberculosis, per 100 000
- SDR(45-59), Tuberculosis, per 100 000
- SDR(60-74), Tuberculosis, per 100 000
- SDR(65+), Tuberculosis, per 100 000
- SDR(75+), Tuberculosis, per 100 000
- SDR, Tuberculosis, per 100 000
- Deaths(#), Ulcer of stomach and duodenum
- SDR(0-14), Ulcer of stomach and duodenum, per 100 000
- SDR(0-64), Ulcer of stomach and duodenum, per 100 000
- SDR(15-29), Ulcer of stomach and duodenum, per 100 000
- SDR(25-64), Ulcer of stomach and duodenum, per 100 000
- SDR(30-44), Ulcer of stomach and duodenum, per 100 000
- SDR(45-59), Ulcer of stomach and duodenum, per 100 000
- SDR(60-74), Ulcer of stomach and duodenum, per 100 000
- SDR(65+), Ulcer of stomach and duodenum, per 100 000
- SDR(75+), Ulcer of stomach and duodenum, per 100 000
- SDR, Ulcer of stomach and duodenum, per 100 000
- Deaths(#), Viral hepatitis
- SDR(0-14), Viral hepatitis, per 100 000
- SDR(0-64), Viral hepatitis, per 100 000
- SDR(15-29), Viral hepatitis, per 100 000
- SDR(25-64), Viral hepatitis, per 100 000
- SDR(30-44), Viral hepatitis, per 100 000
- SDR(45-59), Viral hepatitis, per 100 000
- SDR(60-74), Viral hepatitis, per 100 000
- SDR(65+), Viral hepatitis, per 100 000
- SDR(75+), Viral hepatitis, per 100 000
- SDR, Viral hepatitis, per 100 000
- Mid-year population, age 0 years
- Mid-year population, age 10-14 years
- Mid-year population, age 1-4 years
- Mid-year population, age 15-19 years
- Mid-year population, age 20-24 years
- Mid-year population, age 25-29 years
- Mid-year population, age 30-34 years
- Mid-year population, age 35-39 years
- Mid-year population, age 40-44 years
- Mid-year population, age 45-49 years
- Mid-year population, age 50-54 years
- Mid-year population, age 55-59 years
- Mid-year population, age 5-9 years
- Mid-year population, age 60-64 years
- Mid-year population, age 65-69 years
- Mid-year population, age 70-74 years
- Mid-year population, age 75-79 years
- Mid-year population, age 80-84 years
- Mid-year population, age 85+ years
- Classification version used to code underlying cause of death (see Definitions)
- Influenza vaccination recommendation, elderly
- Influenza vaccination recommendation, pregnant women
- Influenza vaccination recommendation, health care workers
- Influenza vaccination recommendation, long term care facilities
- Influenza vaccination recommendation, children
- Influenza vaccination recommendation, chronic diseases
- Influenza vaccination coverage, elderly
- Influenza vaccination coverage, pregnant women
- Influenza vaccination coverage, health care workers
- Influenza vaccination coverage, long term care facilities
- Influenza vaccination coverage, children first age-group
- Influenza vaccination coverage, children second age-group
- Influenza vaccination coverage, chronic diseases
- Recommendations on nutrition for women of reproductive age
- Recommendations on energy and nutrient intakes for pregnant and lactating women
- Dietary recommendations for at-risk groups
- Nutrition counselling for at-risk groups
- Implementation of recommendations on nutrition
- Review of recommendations on nutrition
- Professionals delivering recommendations on nutrition during pregnancy
- Professionals receiving training on nutrition during pregnancy
- Professionals delivering recommendations on nutrition during postpartum
- Professionals receiving training on nutrition during postpartum
- Training for professionals on nutritional recommendations during pregnancy and the postpartum
- Recommendations on physical activity for women of reproductive age
- Physical activity recommendations for at-risk groups
- Physical activity counselling for at-risk groups
- Implementation of recommendations on physical activity
- Review of recommendations on physical activity
- Recommendations on weight gain during pregnancy
- Recommendations based on pre-pregnancy BMI
- Cut-off for BMI according to WHO standards
- Guidance on frequency of weight recording during pregnancy
- Development and implementation of the recommendations on weight gain during pregnancy
- Professionals responsible for recording and monitoring weight during pregnancy
- Recommendations on newborn, infant and young child nutrition
- Prevention of obesity on newborn, infant and young child nutrition
- Prevention of undernutrition on newborn, infant and young child nutrition
- Nationally available recommendations on newborn, infant and young child nutrition
- Recommended micronutrient intakes for infants and young children
- Paid maternity leave implemented according to law
- Baby Friendly Hospital Initiative
- International code of marketing of breast-milk substitutes incorporated into national legislation
- Integrated Management of Childhood Illness
- Parental leave
- Incorporation of the International Code of Marketing of Breast-milk Substitutes
- Implementation of recommendations on newborn, infant and young child nutrition
- Professionals receiving training in recommendations on newborn, infant and young child nutrition
- Professionals delivering recommendations on newborn, infant and young child nutrition
- Training of professionals related to recommendations on newborn, infant and young child nutrition
- Obesity prevention during the preconception period
- Counselling against excessive weight gain during pregnancy
- Counselling against poor weight gain during pregnancy
- Obesity prevention during the postpartum period
- Areas in which support on guidelines was requested
- Areas in which support on guidelines implementation was requested
- Training for professionals on nutritional recommendations
- Recommendations on energy and nutrient intakes for postpartum women
- Recommendations on weight gain include guidance for each obese class
- Recommendations on physical activity for women during/after pregnancy
- Recommendations on maternal and child healthcare services for obesity
- AMR focal point appointed
- Intersectoral coordinating mechanism
- AMR action plan
- AMR action plan funds
- AMR action plan implementation
- Implementation of action plan monitored
- Enrolled in GLASS
- Coordination AMR surveillance
- AMR surveillance team
- AMR reference laboratory nominated
- Functional AMR reference laboratory
- AMR surveillance
- Periodic surveillance reports
- AMR surveillance network meetings
- CAESAR reporting
- CAESAR external quality assessment
- Laboratory quality assessment system
- Third-generation cephalosporin-resistant Escherichia coli
- Carbapenem-resistant Escherichia coli
- Multidrug-resistant Klebsiella pneumoniae
- Carbapenem-resistant Klebsiella pneumoniae
- Multidrug-resistant Acinetobacter spp.
- Methicillin-resistant Staphylococcus aureus (MRSA)
- National nutrition policies, strategies and action plans
- Higher education training in nutrition
- Trained nutritionists and dieticians working in nutrition-related areas in government or non-government sectors
- Growth monitoring and promotion for children under 5
- Components of growth monitoring and promotion for children under 5
- Breastfeeding promotion and counselling
- Components of breastfeeding promotion and counselling
- Baby-friendly Hospital Initiative (BFHI)
- Complementary feeding counselling or education
- Components of counselling or education on complementary feeding
- School health and nutrition policies, programmes and related standards
- Components of the school health and nutrition policy, programme or standard
- Standards or rules for foods and beverages available in schools
- National dietary guidelines
- Nutrition labelling of foods and beverages
- Nutrition labelling being implemented
- Reformulation measures for foods and beverages
- Reformulation measures to reduce the content of specific nutrients
- Measures to ban or virtually eliminate industrial trans fatty acids
- Fiscal policies for healthy diets
- Measures to regulate or guide marketing of food and non-alcoholic beverages to children
- Measures to regulate or guide marketing of food to children in specific communication channels
- Definitions to restrict marketing of food and non-alcoholic beverages to children
- Measures to control portion sizes
- Media campaigns on healthy diet and nutrition
- Nutrition education and counselling in primary health care or other settings
- Food consumption/nutrient intake surveys
- Nutrients assessed in the food consumption/nutrient intake surveys
- Methods used in the food consumption/nutrient intake surveys in the country
- National CAH strategy exists
- Available budget allocated by government for CAH Strategy
- Stand-alone CAH strategy or part of another strategy
- Strategy review plans before 2020
- Youth involvement in implementation of CAH strategy
- Systems to monitor implementation of CAH strategy exist
- Mechanism for intersectoral planning and implementation of CAH exists
- Ombudsman for children's and adolescent's right
- Ombudsman for CAH right to health
- Consistent national reporting of health under UNCRC
- Production of annual report on the status of children and adolescents
- Data for major interventions disaggregated by rural, suburban and specific urban areas
- Data for major interventions disaggregated by socioeconomic background
- Data for major interventions disaggregated by ethnic background
- Data for major interventions disaggregated by migrant status
- Data for major interventions disaggregated by sex
- National policies on transition from paediatric to adult services exist
- Policies for access to care for adolescents without parental consent exist
- Policies providing guidance for children, adolescents, parents and health workers on consent and confidentiality exist
- All services are provided to adolescents without pay
- Mechanism for assuring quality of care for child and/or adolescents exists
- System for supporting Early Childhood Development exists
- Available data on gaps between staffing levels for children and adolescent health services
- Mechanism for continuous training for adolescent health professional exists
- Hospitalisation rate for children under 5 years
- Hospitalisation rate for children aged 5-9 years
- Hospitalisation rate for children aged 10-14 years
- Hospitalisation rate for children aged 15-18 years
- Hospitalisation rate for pneumonia in children under 5 years
- Legal obligation for perinatal death audits exists
- Information systems exist that separate out services for children
- Information systems exist that separate out services for adolescents
- Systematic information on maternal alcohol consumption is collected
- Policy for initiating exclusive breastfeeding exists
- Data on exclusive breastfeeding is collected based on internationally accepted indicators
- Information is collected systematically on the number of children under 18 treated by mental health professional
- Rate of children treated for ADHD per 100 000 population aged 0-17 years
- Rate of children treated for Autism per 100 000 population aged 0-17 years
- Rate of practicing child psychiatrist per 100 000 population aged 0-14 years
- Rate of practicing child psychologist per 100 000 population aged 0-14 years
- Assessment of quality of mental health services for children and adolescents
- Guidance for transition from child to adult mental health services
- Age of transfer from child to adult mental health services
- Community services for early mental health problems are available
- Data collected on complementary feeding habits for children 6-24 months
- Data collected on the marketing of complementary feeding products for children 6-24 months
- Data collected on the prevalence of overweight/obesity in under 5 children
- Data collected on soft drink consumption for children and adolescents
- Laws or regulations that restrict marketing to children exist
- Legislations that affect the availability of unhealthy foods in school exist
- Plans to address unhealthy products in school before 2020
- Minimum age to purchase beer
- Minimum age to purchase wine
- Minimum age to purchase spirits
- Rate of children in institutional care per 10 000 population aged 0-17
- Rate of children in institutional care per 10 000 population aged 0-2
- Provision of foster care for institutionalised children
- Frequency of population-based survey on child maltreatment
- Child maltreatment surveys completed by children themselves
- Child maltreatment surveys completed by parents
- Child maltreatment surveys completed by institutions
- Collection of systematic information on the health of migrant and refugee children
- Migrant children receive all health care services free of charge
- Migrant children only receive emergency services free of charge
- Migrant children only receive preventive services free of charge
- Migrant children only receive care for chronic conditions free of charge
- Refugee children receive all health care services free of charge
- Refugee children only receive emergency services free of charge
- Refugee children only receive preventive services free of charge
- Refugee children only receive care for chronic conditions free of charge
- Data available on number of single, underage migrant or refugee children using social services
- Health statistics available on the health services provided to at-risk groups
- Policies for the provision of school health services exist
- Coordination of school-based services across government sectors
- National strategy on health promoting schools exists
- National school policy includes adolescent mental health
- Adoption of paediatric essential drug list
- Publicly available paediatric essential drug list
- Paediatric formulations available for all essential drugs
- Data collection on number of drug prescriptions to children and adolescents under 18
- Rate of prescriptions for mental and behavioural disorders per 10 000 for children and adolescents under 18
- Available HPV vaccination through national vaccination programmes free of charge
- Policy on the provision of sexuality education in schools exists
- Information is collected on children's and adolescent's knowledge regarding sexuality
- Legal access to contraception without parental consent for adolescents under 18
- Legal access to abortion without parental consent for adolescents under 18
- Surveys on sexual/intimate partner violence with information on young people under 18
- Age and gender appropriate education that addresses sexual/intimate partner violence
- IHR - National legislation, policy and financing
- IHR - Coordination and National Focal Point communications
- IHR - Surveillance
- IHR - Response
- IHR - Preparedness
- IHR - Risk communication
- IHR - Human resources
- IHR - Laboratory
- IHR - Points of entry
- IHR - Zoonotic events
- IHR - Food safety
- IHR - Chemical events
- IHR - Radionuclear emergencies
- Healthy life years at age 65, Males
- Healthy life years at age 65, Females
- Impoverishing health spending
- Households impoverished after out-of-pocket payments
- Households further impoverished after out-of-pocket payments
- Catastrophic health spending, all households
- Catastrophic health spending, poorest quintile
- Catastrophic health spending, second quintile
- Catastrophic health spending, third quintile
- Catastrophic health spending, fourth quintile
- Catastrophic health spending, richest quintile
- Antibiotic consumption (%)
- Air pollution mortality rate per 100 000 population
- Air pollution mortality rate, males
- Air pollution mortality rate, females
- Urban air pollution
- Road traffic death rate per 100 000 population
- Road traffic death rate, males
- Road traffic death rate, females
- Population using safe drinking water (%)
- Population using safe sanitation (%)
- Antiretroviral therapy coverage (%)
- MDRTB treatment success rate (%)
- Suicide mortality rate per 100 000 population
- Suicide mortality rate, males
- Suicide mortality rate, females
- Premature NCD mortality (%)
- Premature NCD mortality (%), males
- Premature NCD mortality (%), females
- Raised blood pressure prevalence (%)
- Tobacco use prevalence (%)
- Tobacco use prevalence (%), males
- Tobacco use prevalence (%), females
- Overweight prevalence (%)
- Obesity prevalence (%)
- Child overweight prevalence (%), males
- Child overweight prevalence (%), females
- Child obesity prevalence (%), males
- Child obesity prevalence (%), females
- Pneumococcal vaccination coverage (%)
- Medical doctors per 10 000 population
- Nurses per 10 000 population
- Dentists per 10 000 population
- Pharmacists per 10 000 population
- Midwives per 10 000 population
- Health workforce per 10 000 population
- Violence against women (%)
- Hospital access per 100 000 population
- IHR average of capacities
- Children vaccinated against measles (%)
- Trans-fatty acids policy implementation
- Child overweight prevalence (%)
- Child obesity prevalence (%)
- Member States that have HPV vaccination (%)
- Hepatitis C treatment coverage (%)
- Prevalence rate total
- Prevalence rate cardiovascular diseases
- Prevalence rate chronic respiratory diseases
- Prevalence rate mental disorders
- Prevalence rate musculoskeletal disorders
- Prevalence rate neoplasms
- Prevalence rate neurological disorders
- Prevalence rate sensory impairments
- Years lived with disability total
- Years lived with disability cardiovascular diseases
- Years lived with disability chronic respiratory diseases
- Years lived with disability mental disorders
- Years lived with disability musculoskeletal disorders
- Years lived with disability neoplasms
- Years lived with disability neurological disorders
- Years lived with disability sensory impairments
- Recommendations on physical activity
- Levels of physical activity in adults
- Levels of physical activity in children and adolescents
- Coordination mechanism on HEPA promotion
- Funding for HEPA promotion
- Sports for All
- Sports Club for Health
- Access for socially disadvantaged groups
- Special target groups
- Surveillance of physical activity in health
- Counselling on physical activity
- Training of health professionals
- Physical education in schools
- Physical activity promotion in schools
- Training of physical education teachers
- Active travel to school
- Level of cycling and walking
- Infrastructures for leisure-time physical activity
- Active travel to work
- Physical activity at the workplace
- Community interventions for older adults
- Evaluation of HEPA policies
- Awareness campaign on physical activity
- National digital health policy or strategy
- National health information system (HIS) policy or strategy
- National telehealth policy or strategy
- Public funding
- Private or commercial funding
- Donor/non-public funding
- Public-private partnerships
- Digital health education action plan, policy or strategy
- Health professionals: in-service training in digital health
- Health science students: certified training in digital health
- Protects the privacy of personally identifiable data
- Protects the privacy of individuals' health-related data held in electronic format in an EHR
- Governs the sharing of digital data between health professionals and across care settings through the use of an EHR
- Allows individuals electronic access to their own health-related data when held in an EHR
- Allows individuals to demand their own health-related data be corrected when held in an EHR if it is known to be inaccurate
- Allows individuals to demand the deletion of health-related data from their EHR
- Allows individuals to specify which health-related data from their EHR can be shared with health professionals of their choice
- Governs the secure identification of patients and health care providers
- Government agency or organisation responsible for national monitoring
- Government agency or organisation responsible for regional monitoring
- Developed guidance for evaluating digital health interventions
- Evaluation of telehealth programmes
- Evaluation of mHealth service or programmes
- National EHR system
- Regional EHR system
- Regional EHR systems connected or federated at national level
- Primary care facilities (e.g. clinics and health care centres)
- Secondary care facilities (e.g. hospitals, emergency care)
- Tertiary care facilities (e.g. specialized care, referral from primary/secondary care)
- Electronic prescription of medications
- Sharing of clinical/patient medical information with other health professionals
- Receive clinical/patient medical information securely from other professionals
- Receive summary of the care received during a hospitalization upon discharge (such as discharge summary)
- Receive patient summaries
- Send order/request for lab test
- Receive lab test results
- National digital health patient portal
- Booking of medical appointments
- Bring together relevant health-related information
- Shared platform for communication
- Patient access to their medical history and data
- Provider access to patient's clinical information
- Teleradiology
- Teledermatology
- Telepathology
- Telepsychiatry
- Telemedicine
- Appointment reminders
- Mobile teleconsultation
- Patient monitoring
- Treatment adherence
- Access to electronic patient information
- Health promotion
- Surveillance
- General public health announcements
- Management of disasters and emergencies
- Feedback on health care services
- Mindfulness and mental health
- Diet and nutrition
- Exercise and fitness
- Women's health
- COVID-19 symptom checking
- COVID-19 contact-tracing or proximity-tracing
- Booking COVID-19 testing
- Booking COVID-19 vaccination
- Booking care provider consultation
- Overarching national data strategy
- Governs the use of big data in the health sector
- Governs the use of big data in the private sector
- Governs data extraction from EHR systems for regional/local or national registries and databases
- Interoperability strategy or policy
- Responsible national organization or agency
- Adoption of international terminology standards
- Health promotion
- AI strategy for health
- AI strategy cross-sector
- Oversight via existing agency
- Oversight via new agency
- Oversight via advisory board
- Oversight via independent body
- Oversight via multiple agencies
- Legislative measures for AI oversight
- Gap assessment in laws
- Cross-sector guidance
- Amend existing laws
- New cross-sector AI laws
- Sector-specific AI laws
- Sector-specific ethics guidance
- Voluntary industry codes
- Risk-based approach adopted
- Ethical guidelines for AI
- Ethics checklists/toolkits
- Algorithmic impact guidance
- Data protection impact guidance
- Fundamental rights impact guidance
- Existing liability guidance for AI health
- New AI health liability regime
- General AI liability regime
- AI approval regulatory agency
- Regulator knowledge-sharing
- Documentation and record-keeping
- Data accountability
- Validation requirements
- Risk management and cybersecurity
- Post-market monitoring
- AI procurement policies
- AI auditing policies
- AI complaint/redress policies
- AI certification policies
- Environmental impact requirements
- National health data strategy
- Health data governance framework
- Health data authority
- Health data hub
- Data warehouse standards
- Guidance on secondary data use
- EHR data extraction policies
- Routine EHR data integration
- Rules for private data sharing
- Rules for cross-border data sharing
- AI for logistics/admin
- AI chatbots
- AI-assisted surgery
- AI diagnostics
- AI prognosis prediction
- AI symptom checkers
- AI remote monitoring
- Reduce inequalities
- Improve care and outcomes
- Reduce workforce pressure
- Increase efficiencies
- Advance research and discovery
- Strategy barrier
- Legal uncertainty
- Approval processes
- Infrastructure barrier
- Data quality/standards
- Financial affordability
- Evidence gap
- Capacity barrier
- Job displacement
- Trust barrier
- Cultural barrier
- Environmental impact
- Private sector investment
- Cross-border partnerships
- Pre-service AI training
- In-service AI training
- New AI/data roles in health
- Digital Health Strategy Priorities: Accessibility, Quality, Safety, Efficiency
- Digital Health Strategy Priorities: Strengthen Health Information Systems
- Digital Health Strategy Priorities: Enhance Access and Reuse of Health Data
- Digital Health Strategy Priorities: Improve Information Sharing and Interoperability
- Digital Health Strategy Priorities: Strengthen Digital Literacy and Capacity
- Oversight for Digital Health Policy: Multi-stakeholder Governance
- Mandatory Continuing Education in Digital Health for Health Professionals
- National Health Information System (HIS) Policy
- Overarching National Data Strategy
- National Health Data Strategy or Policy
- National Policy for Big Data and Advanced Analytics in Health
- Policy-Relevant Health Indicators in Use
- Formal Procedure for Health Reports in Policy-Making
- Tools for Knowledge Uptake in Policy-Making
- Institutionalized Knowledge Translation in Policy-Making
- National Health Data Governance Framework
- Health Data Authority (National/Regional/Local)
- Formal Multistakeholder Coordination Mechanism for HIS
- Legislation for Privacy of Personally Identifiable Data
- Legislation for Protection and Use of EHR Data
- Legislation for Individual Electronic Access to EHR Data
- Legislation for Digital Data Sharing Across Care Settings
- Laws/Policies for Public Authorities to Extract EHR Data for Registries
- Guidance on Secondary Use of Health Data for Public Interest Research
- Rules for Sharing Health Data with Private Companies for Research
- Rules for Cross-Border Sharing of Health Data for Research
- Existence of National EHR System
- Percentage of Institutions Accessing National EHR
- Availability of Regional/Local EHR Systems
- Percentage of Institutions Accessing Regional/Local EHR
- Connection/Federation of Regional EHR Systems at National Level
- Secure Identification of Patients and Providers
- EHR in Primary Practice Allows Medication Prescription
- EHR Makes Prescriptions Electronically Available to Pharmacies
- EHR Functionality: Medical History
- EHR Functionality: Basic Medical Parameters
- EHR Functionality: Problem List/Diagnoses
- EHR Functionality: Prescriptions/Medications Ordered
- EHR Functionality: Immunizations
- EHR Functionality: Lab Test Results
- Health Data Hub (National/Regional/Local)
- Data Extracted from EHRs and Merged into Registries
- Regular Production of Health Reports
- Use of Health Reports at Facility/Provider Level
- Standalone Interoperability Strategy/Policy
- National Organization/Agency for Clinical Terminology/Messaging Standards
- Legal Requirements for EHR Systems to Conform with National Standards
- Engagement with Software Vendors for EHR Development to Standards
- Quality Label/Certification for Standards Implementation
- Quality Management System for Interoperability Testing
- Consistency of Clinical Terminology Standards Between EHR Systems
- Regular Assessment of EHR Interoperability State
- EHR Barrier: Capacity
- EHR Barrier: Infrastructure
- EHR Barrier: Funding
- EHR Barrier: Effectiveness
- EHR Barrier: Cost-effectiveness
- EHR Barrier: Demand
- EHR Barrier: Legal (Lack of Legislation/Regulations)
- EHR Barrier: Policy (Policies Do Not Promote Adoption)
- EHR Barrier: Standards (Lack of Interoperability Standards)
- EHR Barrier: Competing Priorities
- Big Data and Advanced Analytics Barrier: Different Data Formats
- Big Data and Advanced Analytics Barrier: Promotion of Standards
- Big Data and Advanced Analytics Barrier: Information Sharing
- Big Data and Advanced Analytics Barrier: Building Capacity
- Big Data and Advanced Analytics Barrier: Creation of National Health Databases
- Big Data and Advanced Analytics Barrier: Privacy and Security
- Health expenditure (PPP$ per capita)
- National Strategy and Policy Foundations: Digital health
- National Strategy and Policy Foundations: HIS, data and evidence-informed policymaking
- Data Governance and Legal Frameworks
- Health Data Repositories and Utilization
- Interoperability and Standards
- Barriers to EHR System Implementation
- Barriers to Adopting Big Data & Advanced Analytics for Health
- Electronic Health Records (EHR) Systems
- Data
- European Health for All database (HFA-DB)
- Health information system and data governance
- Artificial Intelligence for Health in the WHO European Region
- Assistive Technology
- European Programme of Work
- Digital Health
- European mortality database (MDB)
- Rehabilitation
- Health-enhancing physical activity
- European database on human and technical resources for health (HlthRes-DB)
- Environment and Health Information System (ENHIS)
- Financial protection in the European Region
- Child and adolescent health
- Seasonal influenza vaccination policies and coverage
- Health Behaviour in School-aged Children (HBSC)
- Maternal nutrition, physical activity and weight gain during pregnancy
- Antimicrobial resistance
- Global nutrition policy survey
- Status of child and adolescent health policies in Europe
- Health 2020 indicators
- Global eHealth survey 2015
- Joint Monitoring Framework (JMF)
- Country profiles
- Albania
- Andorra
- Armenia
- Austria
- Azerbaijan
- Belarus
- Belgium
- Bosnia and Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czechia
- Denmark
- Estonia
- Finland
- France
- Georgia
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Israel
- Italy
- Kazakhstan
- Kyrgyzstan
- Latvia
- Lithuania
- Luxembourg
- Malta
- Monaco
- Montenegro
- Netherlands
- Norway
- Poland
- Portugal
- Republic of Moldova
- Romania
- Russian Federation
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Tajikistan
- North Macedonia
- Türkiye
- Turkmenistan
- Ukraine
- United Kingdom
- Uzbekistan
- Data Stories
- Enhancing national action on environment and health
- Exploring the Health for All family of databases
- State of "Health 2020"
- Report shows progress towards Health 2020 targets
- In focus: Synergistic Health In Emergencies Ladder Development Scale (SHIELDS)
- Child mortality in the WHO European Region down 64% since 2000: Explore updated Health for All and Mortality databases
- Metadata structure of European database on human and technical resources for health
- Exploring the digital health landscape in Europe
- Data and digital health
- Artificial Intelligence for Health in the WHO European Region
- Health information system and data governance
- WHO/Europe Data Warehouse API
- API Specifications
- Search
- Updates
- How-to articles
- General
- About the Gateway
- Cite the European Health Information Gateway
- Health for All explorer
- How to see when an indicator was last updated
- How to export a chart from the HFA explorer and use it in PowerPoint
- How to save a graph for later use
- How to share an Indicators Explorer chart and data with others
- The Gateway
- How to find additional information about an indicator
- How to download the Data Warehouse metadata in Excel format
- How to download an indicator’s data in CSV and Excel formats
- The Data Warehouse and API
- Prerequisites for using API
- How to download the Data Warehouse metadata by using the API
- How to download an indicator’s data using the API
- How to make a bar chart in R